---
layout: page
title: MPEP Patent Appilcation Manual
image:
  feature: /wide/transmission-patent-gray-blueprint.jpg
---
   <head>
      <title>1893-</title>
      <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
</head>
      <li><a href="index.html">Manual of Patent Examining Procedure</a></li>
      <li><a href="mpep-1800.html"><span>Chapter 1800</span></a></li>
      <li><span>Section 1893</span></li>  </ul>
      <div id="yui-main">
         <div class="yui-b">
            <div class="yui-g">  <div xmlns:bf="http://www.uspto.gov/bf" id="article">
               <div>
                  <div xmlns="" class="Section" id="d0e189727">
                     <h1 class="page-title">1893
                        &nbsp;&nbsp;
                        National Stage (U.S. National Application Filed Under 35 U.S.C.
                        			371) [R-08.2012]
                     </h1>
                     <div id="d0e189731" class="CFR">
                        <h4 class="CFR"><i>37&nbsp;C.F.R.&nbsp;1.9&nbsp;
                              
                              
                              
                              Definitions.</i></h4>
                        <ul style="list-style-type: none;">
                           <li id="d0e189736" class="nobull">(a)
                              <ul style="list-style-type: none;">
                                 <li id="d0e189737" class="nobull">(1)  A national
                                    									application as used in this chapter means a U.S. application for
                                    									patent which was either filed in the Office under
                                    										<b><a href="mpep-9015-appx-l.html#d0e302673">35 U.S.C.
                                          										111</a></b> , or which entered the national stage
                                    									from an international application after compliance with
                                    										<b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C.
                                          										371</a></b> . 
                                 </li>
                              </ul>
                           </li>
                           <li id="d0e189747" class="nobull">(2)  A provisional
                              							application as used in this chapter means a U.S. national application
                              							for patent filed in the Office under <b><a href="mpep-9015-appx-l.html#d0e302673">35&nbsp;U.S.C.
                                    								111(b)</a></b> . 
                           </li>
                           <li id="d0e189754" class="nobull">(3)  A nonprovisional
                              							application as used in this chapter means a U.S. national application
                              							for patent which was either filed in the Office under <b><a href="mpep-9015-appx-l.html#d0e302673">35
                                    								U.S.C. 111(a)</a></b> , or which entered the national
                              							stage from an international application after compliance with
                              								<b><a href="mpep-9015-appx-l.html#d0e307164">35&nbsp;U.S.C. 371</a></b> .
                              						
                           </li>
                        </ul>
                        <p class="excludedText"> ***** 
                           
                        </p>
                     </div>
                     <p id="d0e189766"> Thus, there are three types of U.S.
                        			national applications: a national stage application under the PCT (an application which
                        			entered the national stage in the U.S. from an international application after
                        			compliance with <b><a href="mpep-9015-appx-l.html#d0e307164">35&nbsp;U.S.C. 371</a></b> ), a regular domestic
                        			national application filed under <b><a href="mpep-9015-appx-l.html#d0e302673">35 U.S.C. 111(a)</a></b> , and a
                        			provisional application filed under <b><a href="mpep-9015-appx-l.html#d0e302673">35 U.S.C. 111(b)</a></b> . 
                     </p>
                     <p id="d0e189778">An applicant who uses the Patent
                        			Cooperation Treaty gains the benefit of:
                     </p>
                     <div id="d0e189781" class="List">
                        <ul style="list-style-type: none;">
                           <li id="d0e189782" class="nobull">(A) a delay in the time when
                              						papers must be submitted to the national offices;
                           </li>
                           <li id="d0e189786" class="nobull">(B) an international search
                              						(to judge the level of the relevant prior art) and, for international
                              						applications filed on or after January 1, 2004, a written opinion on the
                              						question of whether the claimed invention appears to be novel, to involve an
                              						inventive step (to be non-obvious), and to be industrially applicable before
                              						having to expend resources for filing fees, translations and other
                              						costs;
                           </li>
                           <li id="d0e189790" class="nobull">(C) a delay in the
                              						expenditure of fees;
                           </li>
                           <li id="d0e189794" class="nobull">(D) additional time for
                              						research;
                           </li>
                           <li id="d0e189798" class="nobull">(E) additional time to
                              						evaluate financial, marketing, commercial and other considerations;
                              						and
                           </li>
                           <li id="d0e189802" class="nobull">(F) the option of obtaining
                              						international preliminary examination.
                           </li>
                        </ul>
                     </div>
                     <p id="d0e189806">The time delay is, however, the
                        			benefit most often recognized as primary. Ultimately, applicant might choose to submit
                        			the national stage application. The national stage is unique compared to a domestic
                        			national application in that
                     </p>
                     <div id="d0e189809" class="List">
                        <ul style="list-style-type: none;">
                           <li id="d0e189810" class="nobull">(A)  it is submitted later
                              						(i.e., normally 30&nbsp;months from a claimed priority date as compared to 12
                              						months for a domestic application claiming priority). 
                           </li>
                           <li id="d0e189816" class="nobull">(B) the status of the prior
                              						art is generally known before the national stage begins and this is not
                              						necessarily so in a domestic national application.
                           </li>
                           <li id="d0e189820" class="nobull">(C)  if the filing of an
                              						international application is to be taken into account in determining the
                              						patentability or validity of any application for patent or granted patent,
                              						then special provisions apply. See MPEP §&nbsp; <b><a href="s1895.html#d0e192774">1895.01</a></b> , subsection (E) and MPEP §
                              							<b><a href="s1896.html#d0e193032">1896</a></b> . 
                           </li>
                        </ul>
                     </div>
                     <div class="Section">
                        <h2 class="section1" id="d0e189830">
                           &nbsp;&nbsp;IDENTIFICATION OF THE NATIONAL STAGE APPLICATION
                        </h2>
                        <p id="d0e189834"> Once an international
                           				application entering the U.S. national phase (“national stage application”) has been
                           				accorded a U.S. application number (the two digit series code followed by a six
                           				digit serial number), that number should be used whenever papers or other
                           				communications are directed to the USPTO regarding the national stage application.
                           				See 37 CFR <b><a href="mpep-9020-appx-r.html#d0e313403">1.5</a></b> (a). The national stage
                           				application is tracked through the Patent Application Locating and Monitoring (PALM)
                           				system by the eight digit U.S. application number. Therefore, processing is
                           				expedited if the U.S. application number is indicated. The international application
                           				number, international filing date, and the national stage entry date under 35 U.S.C.
                           					<b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> (if such has been accorded)
                           				should also be included, as such would also be helpful for identification purposes
                           				and can be used to cross-check a possibly erroneous U.S. application number.
                           			
                        </p>
                     </div>
                     <div class="Section">
                        <h1 class="page-title" id="d0e189843">1893.01
                           &nbsp;&nbsp;Commencement and Entry [R-08.2012]
                        </h1>
                        <div id="d0e189849" class="USC">
                           <h4 class="USC"><i>35&nbsp;U.S.C.&nbsp;371&nbsp;
                                 
                                 
                                 
                                 National stage: Commencement.</i></h4>
                           <ul style="list-style-type: none;">
                              <li id="d0e189854" class="nobull">(a) Receipt from the
                                 								International Bureau of copies of international applications with
                                 								any amendments to the claims, international search reports, and
                                 								international preliminary examination reports including any annexes
                                 								thereto may be required in the case of international applications
                                 								designating or electing the United States.
                              </li>
                              <li id="d0e189858" class="nobull">(b)  Subject to
                                 								subsection (f) of this section, the national stage shall commence
                                 								with the expiration of the applicable time limit under
                                 									<b><a href="mpep-9025-appx-t.html#d0e363665">article 22</a></b> (1)
                                 								or (2), or under <b><a href="mpep-9025-appx-t.html#d0e364336">article
                                       									39</a></b> (1)(a) of the treaty. 
                              </li>
                              <li id="d0e189868" class="nobull">(c) The applicant
                                 								shall file in the Patent and Trademark Office —
                                 <ul style="list-style-type: none;">
                                    <li id="d0e189872" class="nobull">(1)  the
                                       										national fee provided in <b><a href="mpep-9015-appx-l.html#d0e301581">section
                                             											41(a)</a></b> of this title; 
                                    </li>
                                    <li id="d0e189879" class="nobull">(2) a copy of
                                       										the international application, unless not required under
                                       										subsection (a) of this section or already communicated by
                                       										the International Bureau, and a translation into the English
                                       										language of the international application, if it was filed
                                       										in another language;
                                    </li>
                                    <li id="d0e189883" class="nobull">(3) 
                                       										amendments, if any, to the claims in the international
                                       										application, made under <b><a href="mpep-9025-appx-t.html#d0e363565">article
                                             											19</a></b> of the treaty, unless such
                                       										amendments have been communicated to the Patent and
                                       										Trademark Office by the International Bureau, and a
                                       										translation into the English language if such amendments
                                       										were made in another language; 
                                    </li>
                                    <li id="d0e189890" class="nobull">(4)  an oath
                                       										or declaration of the inventor (or other person authorized
                                       										under <b><a href="mpep-9015-appx-l.html#d0e302631">chapter
                                             											11</a></b> of this title) complying with the
                                       										requirements of <b><a href="mpep-9015-appx-l.html#d0e302875">section
                                             											115</a></b> of this title and with
                                       										regulations prescribed for oaths or declarations of
                                       										applicants; 
                                    </li>
                                    <li id="d0e189900" class="nobull">(5) a
                                       										translation into the English language of any annexes to the
                                       										international preliminary examination report, if such
                                       										annexes were made in another language.
                                    </li>
                                 </ul>
                              </li>
                              <li id="d0e189904" class="nobull">(d)  The requirement
                                 								with respect to the national fee referred to in subsection (c)(1),
                                 								the translation referred to in subsection (c)(2), and the oath or
                                 								declaration referred to in subsection (c)(4) of this section shall
                                 								be complied with by the date of the commencement of the national
                                 								stage or by such later time as may be fixed by the Director. The
                                 								copy of the international application referred to in subsection
                                 								(c)(2) shall be submitted by the date of the commencement of the
                                 								national stage. Failure to comply with these requirements shall be
                                 								regarded as abandonment of the application by the parties thereof,
                                 								unless it be shown to the satisfaction of the Director that such
                                 								failure to comply was unavoidable. The payment of a surcharge may be
                                 								required as a condition of accepting the national fee referred to in
                                 								subsection (c)(1) or the oath or declaration referred to in
                                 								subsection (c)(4) of this section if these requirements are not met
                                 								by the date of the commencement of the national stage. The
                                 								requirements of subsection (c)(3) of this section shall be complied
                                 								with by the date of the commencement of the national stage, and
                                 								failure to do so shall be regarded as a cancellation of the
                                 								amendments to the claims in the international application made under
                                 									<b><a href="mpep-9025-appx-t.html#d0e363565">article 19</a></b> of
                                 								the treaty. The requirement of subsection (c)(5) shall be complied
                                 								with at such time as may be fixed by the Director and failure to do
                                 								so shall be regarded as cancellation of the amendments made under
                                 									<b><a href="mpep-9025-appx-t.html#d0e364117">article 34</a></b>
                                 								(2)(b) of the treaty. 
                              </li>
                              <li id="d0e189914" class="nobull">(e)  After an
                                 								international application has entered the national stage, no patent
                                 								may be granted or refused thereon before the expiration of the
                                 								applicable time limit under <b><a href="mpep-9025-appx-t.html#d0e363856">article
                                       									28</a></b> or <b><a href="mpep-9025-appx-t.html#d0e364395">article
                                       									41</a></b> of the treaty, except with the express
                                 								consent of the applicant. The applicant may present amendments to
                                 								the specification, claims, and drawings of the application after the
                                 								national stage has commenced. 
                              </li>
                              <li id="d0e189924" class="nobull">(f) At the express
                                 								request of the applicant, the national stage of processing may be
                                 								commenced at any time at which the application is in order for such
                                 								purpose and the applicable requirements of subsection (c) of this
                                 								section have been complied with.
                              </li>
                           </ul>
                        </div>
                        <div id="d0e189928" class="CFR">
                           <h4 class="CFR"><i>37&nbsp;C.F.R.&nbsp;1.491&nbsp;
                                 
                                 
                                 
                                 National stage commencement and entry.</i></h4>
                           <ul style="list-style-type: none;">
                              <li id="d0e189933" class="nobull">(a)  Subject to
                                 									<b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C.
                                       									371(f)</a></b> , the national stage shall commence
                                 								with the expiration of the applicable time limit under
                                 									<b><a href="mpep-9025-appx-t.html#d0e363665">PCT Article 22(1) or
                                       									(2)</a></b> , or under <b><a href="mpep-9025-appx-t.html#d0e364336">PCT Article 39(1)(a)</a></b> . 
                              </li>
                              <li id="d0e189946" class="nobull">(b)  An international
                                 								application enters the national stage when the applicant has filed
                                 								the documents and fees required by <b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C. 371(c)</a></b> within the period set in
                                 									<b><a href="mpep-9020-appx-r.html#d0e329467">§ 1.495</a></b> .
                                 							
                              </li>
                           </ul>
                        </div>
                        <p id="d0e189958"> Subject to 35 U.S.C.
                           					<b><a href="mpep-9015-appx-l.html#d0e307164">371(f)</a></b> , commencement of the
                           				national stage occurs upon expiration of the applicable time limit under PCT Article
                           					<b><a href="mpep-9025-appx-t.html#d0e363665">22</a></b> (1) or (2), or under PCT
                           				Article <b><a href="mpep-9025-appx-t.html#d0e364336">39</a></b> (1)(a). See
                           					<b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C. 371(b)</a></b> and
                           					<b><a href="mpep-9020-appx-r.html#d0e329128">37&nbsp;CFR 1.491(a)</a></b> . PCT Articles
                           					<b><a href="mpep-9025-appx-t.html#d0e363665">22</a></b> (1), <b><a href="mpep-9025-appx-t.html#d0e363665">22</a></b> (2), and <b><a href="mpep-9025-appx-t.html#d0e364336">39</a></b> (1)(a)
                           				provide for a time limit of not later than the expiration of 30 months from the
                           				priority date. Thus, in the absence of an express request for early processing of an
                           				international application under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> (f) and
                           				compliance with the conditions provided therein, the U.S. national stage will
                           				commence upon expiration of 30 months from the priority date of the international
                           				application. Pursuant to 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> (f), the
                           				national stage may commence earlier than 30 months from the priority date, provided
                           				applicant makes an express request for early processing and has complied with the
                           				applicable requirements under 35&nbsp;U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> (c). 
                        </p>
                        <p id="d0e190002"> Entry into the national stage
                           				occurs upon completion of certain acts, as stated in <b><a href="mpep-9020-appx-r.html#d0e329128">37 CFR
                                 					1.491(b)</a></b> . 
                        </p>
                        <div class="Section">
                           <h1 class="page-title" id="d0e190008">1893.01(a) &nbsp;&nbsp;Entry via the U.S. Designated or Elected
                              					Office
                           </h1>
                           <div class="" id="d0e190012">
                              <h4 class="PCT"><i>PCT Article&nbsp;2</i></h4>
                              <h4><i>Definitions</i></h4>
                              <p class="excludedText"> ***** 
                                 
                              </p>
                              <ul style="list-style-type: none;">
                                 <li id="d0e190023" class="nobull">(xiii)  “designated
                                    									Office” means the national Office of or acting for the State
                                    									designated by the applicant under <b><a href="mpep-9025-appx-t.html#d0e363041">Chapter
                                          										I</a></b> of this Treaty; 
                                 </li>
                                 <li id="d0e190030" class="nobull">(xiv)  “elected
                                    									Office” means the national Office of or acting for the State
                                    									elected by the applicant under <b><a href="mpep-9025-appx-t.html#d0e363988">Chapter
                                          										II</a></b> of this Treaty; 
                                 </li>
                              </ul>
                              <p class="excludedText"> ***** 
                                 
                              </p>
                           </div>
                           <div id="d0e190039" class="CFR">
                              <h4 class="CFR"><i>37&nbsp;C.F.R.&nbsp;1.414&nbsp;
                                    
                                    
                                    
                                    The United States Patent and Trademark Office as a
                                    						Designated Office or Elected Office.</i></h4>
                              <ul style="list-style-type: none;">
                                 <li id="d0e190044" class="nobull">(a) The United
                                    									States Patent and Trademark Office will act as a Designated
                                    									Office or Elected Office for international applications in which
                                    									the United States of America has been designated or elected as a
                                    									State in which patent protection is desired.
                                 </li>
                                 <li id="d0e190048" class="nobull">(b) The United
                                    									States Patent and Trademark Office, when acting as a Designated
                                    									Office or Elected Office during international processing will be
                                    									identified by the full title “United States Designated Office”
                                    									or by the abbreviation “DO/US” or by the full title “United
                                    									States Elected Office” or by the abbreviation
                                    									“EO/US.”
                                 </li>
                                 <li id="d0e190052" class="nobull">(c) The major
                                    									functions of the United States Designated Office or Elected
                                    									Office in respect to international applications in which the
                                    									United States of America has been designated or elected,
                                    									include:
                                    <ul style="list-style-type: none;">
                                       <li id="d0e190056" class="nobull">(1) Receiving various notifications throughout the
                                          											international stage and
                                       </li>
                                       <li id="d0e190060" class="nobull">(2) 
                                          											Accepting for national stage examination international
                                          											applications which satisfy the requirements of
                                          												<b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C.
                                                												371</a></b> . 
                                       </li>
                                    </ul>
                                 </li>
                              </ul>
                           </div>
                           <p id="d0e190067"> An international application
                              					designating the U.S. will enter the national stage via the U.S. Designated
                              					Office unless a Demand electing the U.S. is filed under PCT Article
                              						<b><a href="mpep-9025-appx-t.html#d0e363993">31</a></b> whereupon entry will be
                              					via the U.S. Elected Office. The procedure for entry is as prescribed in
                              						<b><a href="mpep-9020-appx-r.html#d0e329467">37 CFR 1.495</a></b> . 
                           </p>
                           <div id="d0e190076" class="CFR">
                              <h4 class="CFR"><i>37&nbsp;C.F.R.&nbsp;1.495&nbsp;
                                    
                                    
                                    
                                    Entering the national stage in the United States of
                                    						America.</i></h4>
                              <ul style="list-style-type: none;">
                                 <li id="d0e190081" class="nobull">(a)  The
                                    									applicant in an international application must fulfill the
                                    									requirements of 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> within the time periods set forth in
                                    									paragraphs (b) and (c) of this section in order to prevent the
                                    									abandonment of the international application as to the United
                                    									States of America. The thirty-month time period set forth in
                                    									paragraphs (b), (c), (d), (e) and (h) of this section may not be
                                    									extended. International applications for which those
                                    									requirements are timely fulfilled will enter the national stage
                                    									and obtain an examination as to the patentability of the
                                    									invention in the United States of America. 
                                 </li>
                                 <li id="d0e190088" class="nobull">(b) To avoid
                                    									abandonment of the application, the applicant shall furnish to
                                    									the United States Patent and Trademark Office not later than the
                                    									expiration of thirty months from the priority
                                    									date:
                                    <ul style="list-style-type: none;">
                                       <li id="d0e190092" class="nobull">(1) A
                                          											copy of the international application, unless it has
                                          											been previously communicated by the International Bureau
                                          											or unless it was originally filed in the United States
                                          											Patent and Trademark Office; and
                                       </li>
                                       <li id="d0e190096" class="nobull">(2)  The
                                          											basic national fee (see § <b><a href="mpep-9020-appx-r.html#d0e329162">1.492</a></b> (a)). 
                                       </li>
                                    </ul>
                                 </li>
                                 <li id="d0e190106" class="nobull">(c)
                                    <ul style="list-style-type: none;">
                                       <li id="d0e190107" class="nobull">(1) If
                                          											applicant complies with paragraph (b) of this section
                                          											before expiration of thirty months from the priority
                                          											date, the Office will notify the applicant if he or she
                                          											has omitted any of:
                                          <ul style="list-style-type: none;">
                                             <li id="d0e190111" class="nobull">(i)  A translation of the
                                                												international application, as filed, into the
                                                												English language, if it was originally filed in
                                                												another language and if any English language
                                                												translation of the publication of the
                                                												international application previously submitted
                                                												under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e303482">154</a></b> (d) (§ <b><a href="mpep-9020-appx-r.html#d0e327633">1.417</a></b> ) is not also a
                                                												translation of the international application as
                                                												filed (35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> (c)(2)); 
                                             </li>
                                             <li id="d0e190124" class="nobull">(ii)  The oath or declaration of the
                                                												inventor (35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> (c)(4) and §
                                                												<b><a href="mpep-9020-appx-r.html#d0e329661">1.497</a></b> ), if a declaration of
                                                												inventorship in compliance with §
                                                												<b><a href="mpep-9020-appx-r.html#d0e329661">1.497</a></b> has not been previously
                                                												submitted in the international application under
                                                												<b><a href="mpep-9025-appx-t.html#d0e366328">PCT
                                                      												Rule 4.17</a></b> (iv) within the time
                                                												limits provided for in <b><a href="mpep-9025-appx-t.html#d0e369930">PCT Rule
                                                      												26</a></b><i>ter</i> .1;
                                                												
                                             </li>
                                             <li id="d0e190145" class="nobull">(iii)  The search fee set forth in §
                                                												<b><a href="mpep-9020-appx-r.html#d0e329162">1.492</a></b> (b); 
                                             </li>
                                             <li id="d0e190152" class="nobull">(iv)  The examination fee set forth in
                                                												§ <b><a href="mpep-9020-appx-r.html#d0e329162">1.492</a></b> (c); and
                                                												
                                             </li>
                                             <li id="d0e190159" class="nobull">(v)  Any application size fee
                                                												required by § <b><a href="mpep-9020-appx-r.html#d0e329162">1.492</a></b> (j); 
                                             </li>
                                          </ul>
                                       </li>
                                       <li id="d0e190166" class="nobull">(2)  A
                                          											notice under paragraph (c)(1) of this section will set a
                                          											time period within which applicant must provide any
                                          											omitted translation, oath or declaration of the
                                          											inventor, search fee set forth in § <b><a href="mpep-9020-appx-r.html#d0e329162">1.492</a></b> (b), examination fee set
                                          											forth in § <b><a href="mpep-9020-appx-r.html#d0e329162">1.492</a></b> (c), and any application
                                          											size fee required by § <b><a href="mpep-9020-appx-r.html#d0e329162">1.492</a></b> (j) in order to avoid
                                          											abandonment of the application. 
                                       </li>
                                       <li id="d0e190179" class="nobull">(3)  The
                                          											payment of the processing fee set forth in §
                                          												<b><a href="mpep-9020-appx-r.html#d0e329162">1.492</a></b> (i) is required for
                                          											acceptance of an English translation later than the
                                          											expiration of thirty months after the priority date. The
                                          											payment of the surcharge set forth in §
                                          												<b><a href="mpep-9020-appx-r.html#d0e329162">
                                                												1.492(h)</a></b> is required for
                                          											acceptance of any of the search fee, the examination
                                          											fee, or the oath or declaration of the inventor after
                                          											the date of the commencement of the national stage (§
                                          												<b><a href="mpep-9020-appx-r.html#d0e329128">1.491</a></b> (a)). 
                                       </li>
                                       <li id="d0e190191" class="nobull">(4)  A
                                          											“Sequence Listing” need not be translated if the
                                          											“Sequence Listing” complies with <b><a href="mpep-9025-appx-t.html#d0e367234">PCT Rule
                                                												12.1</a></b> (d) and the description
                                          											complies with <b><a href="mpep-9025-appx-t.html#d0e366501">PCT
                                                												Rule 5.2</a></b> (b). 
                                       </li>
                                    </ul>
                                 </li>
                                 <li id="d0e190202" class="nobull">(d)  A copy of
                                    									any amendments to the claims made under PCT Article
                                    										<b><a href="mpep-9025-appx-t.html#d0e363565">19</a></b> , and a
                                    									translation of those amendments into English, if they were made
                                    									in another language, must be furnished not later than the
                                    									expiration of thirty months from the priority date. Amendments
                                    									under PCT Article <b><a href="mpep-9025-appx-t.html#d0e363565">19</a></b> which are not received by the
                                    									expiration of thirty months from the priority date will be
                                    									considered to be canceled. 
                                 </li>
                                 <li id="d0e190212" class="nobull">(e)  A
                                    									translation into English of any annexes to an international
                                    									preliminary examination report (if applicable), if the annexes
                                    									were made in another language, must be furnished not later than
                                    									the expiration of thirty months from the priority date.
                                    									Translations of the annexes which are not received by the
                                    									expiration of thirty months from the priority date may be
                                    									submitted within any period set pursuant to paragraph (c) of
                                    									this section accompanied by the processing fee set forth in §
                                    										<b><a href="mpep-9020-appx-r.html#d0e329162">1.492</a></b> (f).
                                    									Annexes for which translations are not timely received will be
                                    									considered canceled. 
                                 </li>
                                 <li id="d0e190219" class="nobull">(f) Verification
                                    									of the translation of the international application or any other
                                    									document pertaining to an international application may be
                                    									required where it is considered necessary, if the international
                                    									application or other document was filed in a language other than
                                    									English.
                                 </li>
                                 <li id="d0e190223" class="nobull">(g)  The
                                    									documents and fees submitted under paragraphs (b) and (c) of
                                    									this section must be clearly identified as a submission to enter
                                    									the national stage under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> .
                                    									Otherwise, the submission will be considered as being made under
                                    									35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e302673">111</a></b> (a
                                    										<b><a href="mpep-9015-appx-l.html#d0e302673">)</a></b> .
                                    								
                                 </li>
                                 <li id="d0e190236" class="nobull">(h) An
                                    									international application becomes abandoned as to the United
                                    									States thirty months from the priority date if the requirements
                                    									of paragraph (b) of this&nbsp;section have not been complied with
                                    									within thirty months from the priority date. If the requirements
                                    									of paragraph (b) of this section are complied with within thirty
                                    									months from the priority date but either of any required
                                    									translation of the international application as filed or the
                                    									oath or declaration are not timely filed, an international
                                    									application will become abandoned as to the United States upon
                                    									expiration of the time period set pursuant to paragraph (c) of
                                    									this section.
                                 </li>
                              </ul>
                           </div>
                           <div class="Section">
                              <h1 class="page-title" id="d0e190240">1893.01(a)(1) &nbsp;&nbsp;Submissions Required by 30 Months from the Priority
                                 						Date [R-08.2012]
                              </h1>
                              <p id="d0e190244"> To begin entry into the
                                 						national stage, applicant is required to comply with 37 CFR
                                 							<b><a href="mpep-9020-appx-r.html#d0e329467">1.495</a></b> (b) within 30
                                 						months from the priority date. Thus, applicant must pay the basic national
                                 						fee on or before 30 months from the priority date and be sure that a copy of
                                 						the international application has been received by the U.S. Designated or
                                 						Elected Office prior to expiration of 30 months from the priority date.
                                 						Where the international application was filed with the United States
                                 						Receiving Office as the competent receiving Office, the copy of the
                                 						international application referred to in 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329467">1.495</a></b> (b) is not required. 
                              </p>
                              <p id="d0e190254"> Facsimile transmission
                                 						is not acceptable for submission of the basic national fee and/or the copy
                                 						of the international application. See 37 CFR <b><a href="mpep-9020-appx-r.html#d0e313447">1.6</a></b> (d). Likewise, the certificate of mailing
                                 						procedures of 37&nbsp;CFR <b><a href="mpep-9020-appx-r.html#d0e313726">1.8</a></b> do not apply to the
                                 						filing of the copy of the international application and payment of the basic
                                 						national fee. See 37 CFR <b><a href="mpep-9020-appx-r.html#d0e313726">1.8</a></b>
                                 						(a)(2)(i)(F). Applicants may file these items using the Express Mail mailing
                                 						procedures set forth in 37 CFR <b><a href="mpep-9020-appx-r.html#d0e313951">1.10</a></b> .
                                 						In addition, applicants may now file national stage submissions online using
                                 						the EFS-Web system. Further information regarding EFS-Web is available at
                                 						http://www.uspto.gov/ebc/efs_help.html. 
                              </p>
                              <p id="d0e190272">Applicants cannot pay the
                                 						basic national fee with a surcharge after the 30 month deadline. Failure to
                                 						pay the basic national fee within 30 months from the priority date will
                                 						result in abandonment of the application. The time for payment of the basic
                                 						fee is not extendable.
                              </p>
                              <p id="d0e190275"> Similarly, the copy of
                                 						the international application required under 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329467">1.495</a></b> (b) must be provided within 30 months from the
                                 						priority date to avoid abandonment. A copy of the international application
                                 						is provided to the U.S. Designated or Elected Office by the International
                                 						Bureau (the copy is ordinarily communicated to the Office on the day of
                                 						publication of the international application at about 18 months from the
                                 						priority date). The International Bureau also mails a confirmation (Form
                                 						PCT/IB/308) to applicant upon which applicant can rely that the copy has
                                 						been provided. This confirmation constitutes conclusive evidence of
                                 						transmission of the international application. See PCT Rule
                                 							<b><a href="mpep-9025-appx-t.html#d0e371659">47.1</a></b> (c). 
                              </p>
                              <p id="d0e190291"> If the basic national
                                 						fee has been paid and the copy of the international application (if
                                 						required) has been received by expiration of 30 months from the priority
                                 						date, but the required oath or declaration, translation, search fee (
                                 							<b><a href="mpep-9020-appx-r.html#d0e329162">37 CFR 1.492</a></b> (b)),
                                 						examination fee ( <b><a href="mpep-9020-appx-r.html#d0e329162">37 CFR 1.492</a></b> (c)), or
                                 						application size fee ( <b><a href="mpep-9020-appx-r.html#d0e329162">37 CFR 1.492</a></b> (j)) has
                                 						not been filed prior to commencement of the national stage (see MPEP §
                                 							<b><a href="s1893.html#d0e189843">1893.01</a></b> ), the Office will
                                 						send applicant a notice identifying any deficiency and provide a period of
                                 						time to correct the deficiency as set forth in 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329467">1.495</a></b> (c). The time period usually set is 2 months
                                 						from the date of the notification by the Office or 32 months from the
                                 						priority date, whichever is later. This period may be extended for up to 5
                                 						additional months pursuant to the provisions of 37 CFR <b><a href="mpep-9020-appx-r.html#d0e323655">1.136</a></b> (a). Failure to timely file the proper reply
                                 						to the notification will result in abandonment of the national stage
                                 						application. The processing fee set forth in 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329162">1.492</a></b> (i) will be required for acceptance of an
                                 						English translation of the international application later than the
                                 						expiration of thirty months after the priority date, and the surcharge fee
                                 						set forth in 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329162">1.492</a></b> (h) will be
                                 						required for acceptance of any of the search fee, examination fee, or oath
                                 						or declaration of the inventor after the date of commencement. 37 CFR
                                 							<b><a href="mpep-9020-appx-r.html#d0e329467">1.495</a></b> (c)(3). 
                              </p>
                              <p id="d0e190321"> For further information
                                 						regarding the oath or declaration required under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> (c)(4) and 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329661">1.497</a></b> for entry into the U.S. national phase, see
                                 						MPEP § <b><a href="s1893.html#d0e190737">1893.01(e)</a></b> . 
                              </p>
                              <p id="d0e190333"> For further information
                                 						regarding the translation required under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> (c)(2) and 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329467">1.495</a></b> (c), see MPEP § <b><a href="s1893.html#d0e189843">1893.01(d)</a></b> . 
                              </p>
                           </div>
                           <div class="Section">
                              <h1 class="page-title" id="d0e190345">1893.01(a)(2) &nbsp;&nbsp;Article 19 Amendment (Filed With the International
                                 						Bureau) [R-08.2012]
                              </h1>
                              <p id="d0e190349"> The claims of an
                                 						international application may be amended under PCT Article <b><a href="mpep-9025-appx-t.html#d0e363565">19</a></b> after issuance of the search report. The
                                 						description and drawings may not be amended under PCT Article
                                 							<b><a href="mpep-9025-appx-t.html#d0e363565">19</a></b> . The amendment is
                                 						forwarded to the U.S. Designated Office by the International Bureau for
                                 						inclusion in the U.S. national stage application. Article <b><a href="mpep-9025-appx-t.html#d0e363565">19</a></b> amendments which were made in English will be
                                 						entered by substituting each page of amendment for the corresponding English
                                 						language page of claims of the international application. If the Article
                                 							<b><a href="mpep-9025-appx-t.html#d0e363565">19</a></b> amendments were made
                                 						in a language other than English, applicant must provide an English
                                 						translation for the U.S. national stage application. The Article 19
                                 						amendment(s) and the English translation of the amendment(s) must be
                                 						received by the Office by the date of commencement of the national stage
                                 						(see MPEP § <b><a href="s1893.html#d0e189843">1893.01</a></b> ) . Otherwise, the
                                 						amendment(s) will be considered to be canceled, 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> (d). If such canceled amendments are desired,
                                 						they must be offered under <b><a href="mpep-9020-appx-r.html#d0e323020">37&nbsp;CFR
                                       							1.121</a></b> as a preliminary amendment or a responsive
                                 						amendment under <b><a href="mpep-9020-appx-r.html#d0e322449">37&nbsp;CFR 1.111</a></b> . 
                              </p>
                              <p id="d0e190381"> Applicants entering the
                                 						national stage in the U.S. are encouraged to submit an amendment in
                                 						accordance with <b><a href="mpep-9020-appx-r.html#d0e323020">37 CFR 1.121</a></b> rather
                                 						than an English translation of an <b><a href="mpep-9025-appx-t.html#d0e363565">Article
                                       							19</a></b> amendment. Sometimes when an <b><a href="mpep-9025-appx-t.html#d0e363565">Article
                                       							19</a></b> amendment is translated into English, it cannot be
                                 						entered. That is, each page of an <b><a href="mpep-9025-appx-t.html#d0e363565">Article
                                       							19</a></b> amendment must be entered by substituting a page
                                 						of amendment for the corresponding page of claims of the international
                                 						application. After translation of a page, the translated page may no longer
                                 						correspond to a page of the claims of the international application such
                                 						that the amendment is capable of entry by substituting the page of English
                                 						translation (of the amendment) for the corresponding page of claims of the
                                 						international application without leaving an inconsistency. Where applicant
                                 						chooses to submit an English translation of the <b><a href="mpep-9025-appx-t.html#d0e363565">Article
                                       							19</a></b> amendment, applicant should check to be sure that
                                 						the English translation can be entered by substituting the pages of
                                 						translation for corresponding pages of the claims of the international
                                 						application without leaving an inconsistency. If entry of the page of
                                 						translation causes inconsistencies in the claims of the international
                                 						application the translation will not be entered. For example, if the
                                 						translation of the originally filed application has a page which begins with
                                 						claim 1 and ends with a first part of claim 2 with the remainder of claim 2
                                 						on the next page then translation of the Article 19 amendment to only claim
                                 						1 must include a substitute page or pages beginning with the changes to
                                 						claim 1 and ending with the last of the exact same first part of claim 2.
                                 						This enables the original translated first page of claims to be replaced by
                                 						the translation of the amendment without changing the subsequent unamended
                                 						page(s). Alternatively, applicant may submit a preliminary amendment in
                                 						accordance with <b><a href="mpep-9020-appx-r.html#d0e323020">37 CFR 1.121</a></b> .
                                 					
                              </p>
                           </div>
                           <div class="Section">
                              <h1 class="page-title" id="d0e190402">1893.01(a)(3) &nbsp;&nbsp;Article 34 Amendments (Filed with the International
                                 						Preliminary Examining Authority) [R-08.2012]
                              </h1>
                              <p id="d0e190410"> Amendments to the
                                 						international application that were properly made under PCT Article
                                 							<b><a href="mpep-9025-appx-t.html#d0e364117">34</a></b> during the
                                 						international preliminary examination phase (i.e., Chapter II) will be
                                 						annexed by the International Preliminary Examining Authority to the
                                 						international preliminary examination report (IPER) and communicated to the
                                 						elected Offices. See PCT Article <b><a href="mpep-9025-appx-t.html#d0e364231">36</a></b> ,
                                 						PCT Rule <b><a href="mpep-9025-appx-t.html#d0e375629">70.16</a></b> , and MPEP §
                                 							<b><a href="s1893.html#d0e192440">1893.03(e)</a></b> . If these
                                 						annexes are in English, they will normally be entered into the U.S. national
                                 						stage application by the Office absent a clear instruction by the applicant
                                 						that the annexes are not to be entered. However, if entry of the replacement
                                 						sheets will result in an obvious inconsistency in the description, claims or
                                 						drawings of the international application, then the annexes will not be
                                 						entered. If the annexes are in a foreign language, a proper translation of
                                 						the annexes must be furnished to the Office not later than the expiration of
                                 						30 months from the priority date, unless a period has been set pursuant to
                                 						37 CFR <b><a href="mpep-9020-appx-r.html#d0e329467">1.495</a></b> (c) to furnish an
                                 						oath or declaration , English translation of the international application,
                                 						search fee ( <b><a href="mpep-9020-appx-r.html#d0e329162">37 CFR 1.492</a></b> (b)),
                                 						examination fee ( <b><a href="mpep-9020-appx-r.html#d0e329162">37 CFR 1.492</a></b> (c)), or
                                 						application size fee ( <b><a href="mpep-9020-appx-r.html#d0e329162">37&nbsp;CFR 1.492</a></b> (j)), in
                                 						which case the translations of the annexes, accompanied by the processing
                                 						fee set forth in 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329162">1.492</a></b> (f), may be
                                 						submitted within the period set pursuant to 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329467">1.495</a></b> (c). See 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329467">1.495</a></b> (e). Annexes for which translations are not
                                 						timely received will be considered canceled. Amendments made under PCT
                                 						Article <b><a href="mpep-9025-appx-t.html#d0e364117">34</a></b> to the international
                                 						application after commencement and entry into the U.S. national phase (see
                                 						MPEP § <b><a href="s1893.html#d0e189843">1893.01</a></b> ) will not be
                                 						considered in a U.S. national stage application. However, applicants may
                                 						still amend the U.S. national stage application by way of a preliminary
                                 						amendment submitted in accordance with 37 CFR <b><a href="mpep-9020-appx-r.html#d0e322734">1.115</a></b> and 37&nbsp;CFR <b><a href="mpep-9020-appx-r.html#d0e323020">1.121</a></b>
                                 						. 
                              </p>
                              <p id="d0e190468"> Where an English
                                 						translation of the annexes is provided, the translation must be such that
                                 						the translation of the originally filed application can be changed by
                                 						replacing the originally filed application page(s) (of translation) with
                                 						substitute page(s) of translation of the annex. Thus, applicant should check
                                 						to be sure that the English translation can be entered by substituting the
                                 						pages of translation for corresponding pages of the claims of the
                                 						international application without leaving an inconsistency. If entry of the
                                 						page of translation causes inconsistencies in the specification or claims of
                                 						the international application the translation will not be entered. Non-entry
                                 						of the annexes will be indicated on the “NOTICE OF ACCEPTANCE OF APPLICATION
                                 						UNDER 35&nbsp;U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> AND 37 CFR
                                 							<b><a href="mpep-9020-appx-r.html#d0e329467">1.495</a></b> ” (Form
                                 						PCT/DO/EO/903). For example, if the translation of the originally filed
                                 						application has a page which begins with claim 1 and ends with a first part
                                 						of claim 2 with the remainder of claim 2 on the next page then translation
                                 						of the annex to only claim 1 must include a substitute page or pages
                                 						beginning with the changes to claim 1 and ending with the last of the
                                 						exact&nbsp;same first part of claim 2. This enables the original translated first
                                 						page of claims to be replaced by the translation of the annex without
                                 						changing the subsequent unamended page(s). Alternatively applicant may
                                 						submit a preliminary amendment in accordance with <b><a href="mpep-9020-appx-r.html#d0e323020">37 CFR
                                       							1.121</a></b> . The fact that an amendment made to the
                                 						international application during the international phase was entered in the
                                 						national stage application does not necessarily mean that the amendment is
                                 						proper. Specifically, amendments are not permitted to introduce “new matter”
                                 						into the application. See PCT Article <b><a href="mpep-9025-appx-t.html#d0e364117">34</a></b>
                                 						(2)(b). Where it is determined that such amendments introduce new matter
                                 						into the application, then the examiner should proceed as in the case of
                                 						regular U.S. national applications filed under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e302673">111</a></b> (a) by requiring removal of the new matter and
                                 						making any necessary rejections to the claims. See MPEP §
                                 							<b><a href="s608.html#d0e50812">608.04</a></b> and §
                                 							<b><a href="s2163.html#d0e215023">2163.06</a></b> . 
                              </p>
                           </div>
                        </div>
                        <div class="Section">
                           <h1 class="page-title" id="d0e190492">1893.01(c) &nbsp;&nbsp;Fees</h1>
                           <p id="d0e190496"> Because the national stage
                              					fees are subject to change, applicants and examiners should always consult the
                              						<i>Official Gazette</i> for the current fee
                              					listing. 
                           </p>
                           <p id="d0e190502"> The basic national fee must
                              					be paid prior to the expiration of 30 months from the priority date to avoid
                              					abandonment of the international application as to the United States. This time
                              					period is not extendable. 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329467">1.495</a></b>
                              					(a)-(b). The search fee required under 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329162">1.492</a></b> (b) and examination fee required under 37 CFR
                              						<b><a href="mpep-9020-appx-r.html#d0e329162">1.492</a></b> (c) are due on
                              					commencement of the national stage (37 CFR <b><a href="mpep-9020-appx-r.html#d0e329128">1.491</a></b>
                              					(a)), but may be accepted later with the payment of a surcharge. 37 CFR
                              						<b><a href="mpep-9020-appx-r.html#d0e329467">1.495</a></b> (c)(3). 
                           </p>
                           <p id="d0e190522"> Fees under 37 CFR
                              						<b><a href="mpep-9020-appx-r.html#d0e314702">1.16</a></b> relate to national
                              					applications under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e302673">111</a></b> (a),
                              					and not to international applications entering the national stage under
                              					35&nbsp;U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> . National stage fees
                              					are specifically provided for in 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329162">1.492</a></b> .
                              					However, an authorization to charge fees under 37 CFR <b><a href="mpep-9020-appx-r.html#d0e314702">1.16</a></b> in an international application entering the
                              					national stage under 35&nbsp;U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> will
                              					be treated as an authorization to charge fees under 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329162">1.492</a></b> . See 37 CFR <b><a href="mpep-9020-appx-r.html#d0e316815">1.25</a></b> (b).
                              					Accordingly, applications&nbsp;will not be held abandoned if an authorization to
                              					charge fees under 37&nbsp;CFR <b><a href="mpep-9020-appx-r.html#d0e314702">1.16</a></b> has been provided
                              					instead of an authorization to charge fees under 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329162">1.492</a></b> . 
                           </p>
                           <p id="d0e190555"> A preliminary amendment
                              					accompanying the initial national stage submission under 35 U.S.C.
                              						<b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> that is effective to
                              					cancel claims and/or eliminate multiple dependent claims will be effective to
                              					reduce the number of claims to be considered in calculating extra claim fees
                              					required under 37&nbsp;CFR <b><a href="mpep-9020-appx-r.html#d0e329162">1.492</a></b> (d)-(e) and/or
                              					eliminate the multiple dependent claim fee required under 37&nbsp;CFR
                              						<b><a href="mpep-9020-appx-r.html#d0e329162">1.492</a></b> (f). A subsequently
                              					filed amendment canceling claims and/or eliminating multiple dependent claims
                              					will not entitle applicant to a refund of fees previously paid. See MPEP §
                              						<b><a href="s607.html#d0e41804">607</a></b> and §
                              						<b><a href="s608.html#d0e42401">608</a></b> . 
                           </p>
                           <p id="d0e190585"> The application size fee for
                              					a national stage application (37 CFR <b><a href="mpep-9020-appx-r.html#d0e329162">1.492</a></b> (j))
                              					is determined on the basis of the international application as published by WIPO
                              					pursuant to PCT Article <b><a href="mpep-9025-appx-t.html#d0e363622">21</a></b> . Specifically, the
                              					application size fee is calculated on the basis of the number of sheets of
                              					description, claims, drawings, and abstract present in the published
                              					international application. This calculation is made without regard to the
                              					language of publication. Certain other sheets typically present in the
                              					international publication are not taken into account in determining the
                              					application size fee, i.e., Article <b><a href="mpep-9025-appx-t.html#d0e363565">19</a></b>
                              					amendments, the international search report, and any additional bibliographic
                              					sheets (other than the cover sheet containing the abstract). Nor are Article
                              						<b><a href="mpep-9025-appx-t.html#d0e364117">34</a></b> amendments or
                              					preliminary amendments taken into account in determining the application size
                              					fee. For tables related to sequence listings that were submitted under PCT
                              					Administrative Instructions Section <b><a href="mpep-9030-appx-ai.html#d0e284717">801</a></b> in the
                              					international stage and furnished in the U.S. national stage: 
                           </p>
                           <div id="d0e190603" class="List">
                              <ul style="list-style-type: none;">
                                 <li id="d0e190604" class="nobull">(A)  as a text file
                                    								via EFS-Web or in an electronic medium in accordance with 37 CFR
                                    									<b><a href="mpep-9020-appx-r.html#d0e318327">1.52</a></b> (f)(1),
                                    								each three kilobytes of content submitted shall be counted as a
                                    								sheet of paper; 
                                 </li>
                                 <li id="d0e190611" class="nobull">(B) on paper, the
                                    								number of sheets actually received are counted;
                                 </li>
                                 <li id="d0e190615" class="nobull">(C)  as a PDF file
                                    								submitted through EFS-Web, the number of pages as rendered by the
                                    								Office electronic filing system are counted. The paper size
                                    								equivalency provisions of 37 CFR <b><a href="mpep-9020-appx-r.html#d0e318327">1.52</a></b> (f)(2) for EFS-Web filings do not apply
                                    								to national stage submissions. 
                                 </li>
                              </ul>
                           </div>
                           <p id="d0e190623"> The processing fee set forth
                              					in 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329162">1.492</a></b> (i) will be required
                              					for acceptance of an English translation of the international application later
                              					than the expiration of thirty months after the priority date, and the surcharge
                              					fee set forth in 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329162">1.492</a></b> (h) will be required
                              					for acceptance of any of the search fee, examination fee, or oath or declaration
                              					of the inventor after the date of commencement. 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329467">1.495</a></b> (c)(3). 
                           </p>
                        </div>
                        <div class="Section">
                           <h1 class="page-title" id="d0e190635">1893.01(d) &nbsp;&nbsp;Translation</h1>
                           <p id="d0e190639"> Applicants entering the
                              					national stage in the U.S. are required to file an English translation of the
                              					international application if the international application was filed in another
                              					language and was not published under PCT Article <b><a href="mpep-9025-appx-t.html#d0e363622">21</a></b> (2) in English. <b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C.
                                    						371(c)</a></b> (2) and <b><a href="mpep-9020-appx-r.html#d0e329467">37 CFR
                                    						1.495(c)</a></b> . A “Sequence Listing” need not be translated if
                              					the “Sequence Listing” complies with <b><a href="mpep-9025-appx-t.html#d0e367234">PCT Rule
                                    						12.1(d)</a></b> and the description complies with
                              						<b><a href="mpep-9025-appx-t.html#d0e366501">PCT Rule 5.2(b)</a></b> . See
                              						<b><a href="mpep-9020-appx-r.html#d0e329467">37 CFR 1.495(c)</a></b> . The
                              					translation must be a translation of the international application as filed or
                              					with any changes which have been properly accepted under <b><a href="mpep-9025-appx-t.html#d0e369418">PCT Rule
                                    						26</a></b> or any rectifications which have been properly
                              					accepted under <b><a href="mpep-9025-appx-t.html#d0e377673">PCT Rule 91</a></b> . A translation
                              					of less than all of the international application (e.g., a translation that
                              					fails to include a translation of text contained in the drawings or a
                              					translation that includes a translation of claims amended under PCT Article
                              						<b><a href="mpep-9025-appx-t.html#d0e363565">19</a></b> or <b><a href="mpep-9025-appx-t.html#d0e364117">34</a></b> but does not include a translation of the original
                              					claims) is unacceptable. In addition, a translation that includes modifications
                              					other than changes that have been properly accepted under PCT Rule
                              						<b><a href="mpep-9025-appx-t.html#d0e369418">26</a></b> or <b><a href="mpep-9025-appx-t.html#d0e377673">91</a></b> (e.g., a translation that includes headings that were
                              					not present in the international application as originally filed) is
                              					unacceptable. A translation of words contained in the drawings must be furnished
                              					either in the form of new drawings or in the form of a copy of the original
                              					drawings with the translation pasted on the original text matter. See PCT Rule
                              						<b><a href="mpep-9025-appx-t.html#d0e372401">49.5</a></b> (d). 
                           </p>
                           <p id="d0e190681"> Amendments, even those
                              					considered to be minor or to not include new matter, may not be incorporated
                              					into the translation. If an amendment to the international application as filed
                              					is desired for the national stage, it may be submitted in accordance with
                              						<b><a href="mpep-9020-appx-r.html#d0e323020">37&nbsp;CFR 1.121</a></b> . An amendment
                              					filed under <b><a href="mpep-9020-appx-r.html#d0e323020">37 CFR 1.121</a></b> should be
                              					submitted within 3 months after completion of the <b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C.
                                    						371(c)</a></b> requirements for entry into the national stage.
                              					See <b><a href="mpep-9020-appx-r.html#d0e329630">37&nbsp;CFR</a></b><b><a href="mpep-9020-appx-r.html#d0e322734"> 1.115 </a></b> (b)(3)(iii) . If
                              					applicant has timely paid the basic national fee and submitted the copy of the
                              					international application but the translation is missing or is defective, a
                              					Notification of Missing Requirements (PCT/DO/EO/905) will be sent to applicant
                              					setting a period to correct any missing or defective requirements. The time
                              					period is 32 months from the priority date or 2 months from the date of the
                              					notice, whichever expires later. The time period may be extended for up to five
                              					additional months as provided in <b><a href="mpep-9020-appx-r.html#d0e323655">37 CFR
                                    						1.136(a).</a></b> A processing fee is required for accepting a
                              					translation after 30 months from the priority date. See 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329162">1.492</a></b> (i). 
                           </p>
                           <p id="d0e190719"> Pursuant to PCT Rule
                              						<b><a href="mpep-9025-appx-t.html#d0e372152">48.3</a></b> (c), if the
                              					international application is published in a language other than English, the
                              					publication shall include an English translation of the title of the invention,
                              					the abstract, and any text matter pertaining to the figure or figures
                              					accompanying the abstract. The translations shall be prepared under the
                              					responsibility of the International Bureau. 
                           </p>
                           <p id="d0e190725"> A translation of the
                              					international application as filed and identified as provided in 37 CFR
                              						<b><a href="mpep-9020-appx-r.html#d0e327633">1.417</a></b> submitted for the
                              					purpose of obtaining provisional rights pursuant to 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e303482">154</a></b> (d)(4) can be relied on to fulfill the translation
                              					requirement under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> (c)(2) in a national
                              					stage application. 
                           </p>
                        </div>
                        <div class="Section">
                           <h1 class="page-title" id="d0e190737">1893.01(e) &nbsp;&nbsp;Oath/Declaration</h1>
                           <div id="d0e190741" class="CFR">
                              <h4 class="CFR"><i>37&nbsp;C.F.R.&nbsp;1.497&nbsp;
                                    
                                    
                                    
                                    Oath or declaration under 35 U.S.C.
                                    						371(c)(4).</i></h4>
                              <ul style="list-style-type: none;">
                                 <li id="d0e190746" class="nobull">(a)  When an
                                    									applicant of an international application desires to enter the
                                    									national stage under <b><a href="mpep-9015-appx-l.html#d0e307164">35&nbsp;U.S.C.
                                          										371</a></b> pursuant to § <b><a href="mpep-9020-appx-r.html#d0e329467">1.495</a></b> , and
                                    									a declaration in compliance with this section has not been
                                    									previously submitted in the international application under PCT
                                    									Rule <b><a href="mpep-9025-appx-t.html#d0e366328">4.17(iv)</a></b>
                                    									within the time limits provided for in PCT Rule
                                    										<b><a href="mpep-9025-appx-t.html#d0e369418"> 26 ter .1, </a></b> he or she must
                                    									file an oath or declaration that: 
                                    <ul style="list-style-type: none;">
                                       <li id="d0e190765" class="nobull">(1)  Is
                                          											executed in accordance with either §§&nbsp; <b><a href="mpep-9020-appx-r.html#d0e319973">1.66</a></b> or <b><a href="mpep-9020-appx-r.html#d0e320076">1.68</a></b> ; 
                                       </li>
                                       <li id="d0e190775" class="nobull">(2) Identifies the specification to which it is
                                          											directed;
                                       </li>
                                       <li id="d0e190779" class="nobull">(3) Identifies each inventor and the country of citizenship
                                          											of each inventor; and
                                       </li>
                                       <li id="d0e190783" class="nobull">(4) States that the person making the oath or declaration
                                          											believes the named inventor or inventors to be the
                                          											original and first inventor or inventors of the subject
                                          											matter which is claimed and for which a patent is
                                          											sought.
                                       </li>
                                    </ul>
                                 </li>
                                 <li id="d0e190787" class="nobull">(b)
                                    <ul style="list-style-type: none;">
                                       <li id="d0e190788" class="nobull">(1)  The
                                          											oath or declaration must be made by all of the actual
                                          											inventors except as provided for in <b><a href="mpep-9020-appx-r.html#d0e317787">§§&nbsp;1.42</a></b> , <b><a href="mpep-9020-appx-r.html#d0e317800">1.43</a></b> or <b><a href="mpep-9020-appx-r.html#d0e317892">1.47</a></b> . 
                                       </li>
                                       <li id="d0e190801" class="nobull">(2)  If
                                          											the person making the oath or declaration or any
                                          											supplemental oath or declaration is not the inventor (§§
                                          												<b><a href="mpep-9020-appx-r.html#d0e317787">1.42</a></b> , 1.43, or §1.47), the oath
                                          											or declaration shall state the relationship of the
                                          											person to the inventor, and, upon information and
                                          											belief, the facts which the inventor would have been
                                          											required to state. If the person signing the oath or
                                          											declaration is the legal representative of a deceased
                                          											inventor, the oath or declaration shall also state that
                                          											the person is a legal representative and the
                                          											citizenship, residence and mailing address of the legal
                                          											representative. 
                                       </li>
                                    </ul>
                                 </li>
                                 <li id="d0e190808" class="nobull">(c)  Subject to
                                    									paragraph (f) of this section, if the oath or declaration meets
                                    									the requirements of paragraphs (a) and (b) of this section, the
                                    									oath or declaration will be accepted as complying with
                                    										<b><a href="mpep-9015-appx-l.html#d0e307164">35&nbsp;U.S.C.
                                          										371</a></b> (c)(4) and § <b><a href="mpep-9020-appx-r.html#d0e329467">1.495</a></b> (c).
                                    									However, if the oath or declaration does not also meet the
                                    									requirements of <b><a href="mpep-9020-appx-r.html#d0e319759">§&nbsp;1.63</a></b> , a supplemental oath or
                                    									declaration in compliance with <b><a href="mpep-9020-appx-r.html#d0e319759">§&nbsp;1.63</a></b> or
                                    									an application data sheet will be required in accordance with
                                    										<b><a href="mpep-9020-appx-r.html#d0e319992">§ 1.67</a></b> .
                                    								
                                 </li>
                                 <li id="d0e190827" class="nobull">(d)  If the oath
                                    									or declaration filed pursuant to 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371(c)(4)</a></b>
                                    									and this section names an inventive entity different from the
                                    									inventive entity set forth in the international application, or
                                    									if a change to the inventive entity has been effected under PCT
                                    										<b><a href="mpep-9025-appx-t.html#d0e378036"> Rule 92 bis</a></b> subsequent to the execution of any oath or
                                    									declaration which was filed in the application under PCT Rule
                                    										<b><a href="mpep-9025-appx-t.html#d0e366328">4.17</a></b> (iv)
                                    									or this section and the inventive entity thus changed is
                                    									different from the inventive entity identified in any such oath
                                    									or declaration, applicant must submit: 
                                    <ul style="list-style-type: none;">
                                       <li id="d0e190842" class="nobull">(1) A
                                          											statement from each person being added as an inventor
                                          											and from each person being deleted as an inventor that
                                          											any error in inventorship in the international
                                          											application occurred without deceptive intention on his
                                          											or her part;
                                       </li>
                                       <li id="d0e190846" class="nobull">(2)  The
                                          											processing fee set forth in § <b><a href="mpep-0010-title-page.html#d0e315199">1.17(i)</a></b> ; and 
                                       </li>
                                       <li id="d0e190853" class="nobull">(3)  If
                                          											an assignment has been executed by any of the original
                                          											named inventors, the written consent of the assignee
                                          											(see § <b><a href="mpep-9020-appx-r.html#d0e336732">3.73(b)</a></b> of this chapter); and
                                          										
                                       </li>
                                       <li id="d0e190860" class="nobull">(4) Any
                                          											new oath or declaration required by paragraph (f) of
                                          											this section.
                                       </li>
                                    </ul>
                                 </li>
                                 <li id="d0e190864" class="nobull">(e) The Office
                                    									may require such other information as may be deemed appropriate
                                    									under the particular circumstances surrounding the correction of
                                    									inventorship.
                                 </li>
                                 <li id="d0e190868" class="nobull">(f)  A new oath
                                    									or declaration in accordance with this section must be filed to
                                    									satisfy 35 U.S.C <b><a href="mpep-9015-appx-l.html#d0e307164">.
                                          										371(c)(4)</a></b> if the declaration was filed
                                    									under PCT Rule <b><a href="mpep-9025-appx-t.html#d0e366328">4.17(iv)</a></b> , and: 
                                    <p id="d0e190878" style="margin-left: 12pt;"></p>
                                    <ul style="list-style-type: none;">
                                       <li id="d0e190883" class="nobull">(1) 
                                          											There was a change in the international filing date
                                          											pursuant to PCT <b><a href="mpep-9025-appx-t.html#d0e368849">Rule
                                                												20.5(c)</a></b> after the declaration was
                                          											executed; or 
                                       </li>
                                       <li id="d0e190891" class="nobull">(2)  A
                                          											change in the inventive entity was effected under PCT
                                          												<b><a href="mpep-9025-appx-t.html#d0e378036"> Rule 92 bis</a></b> after the declaration was executed
                                          											and no declaration which sets forth and is executed by
                                          											the inventive entity as so changed has been filed in the
                                          											application. 
                                       </li>
                                    </ul>
                                 </li>
                                 <li id="d0e190900" class="nobull">(g)  If a
                                    									priority claim has been corrected or added pursuant to PCT
                                    										<b><a href="mpep-9025-appx-t.html#d0e369679"> Rule 26 bis</a></b> during the international stage after the
                                    									declaration of inventorship was executed in the international
                                    									application under PCT <b><a href="mpep-9025-appx-t.html#d0e366328">Rule
                                          										4.17(iv)</a></b> , applicant will be required to
                                    									submit either a new oath or declaration or an application data
                                    									sheet as set forth in § <b><a href="mpep-9020-appx-r.html#d0e320348">1.76</a></b> correctly identifying the
                                    									application upon which priority is claimed. 
                                 </li>
                              </ul>
                           </div>
                           <p id="d0e190915"> Applicants entering the
                              					national stage in the U.S. are required to file an oath or declaration of the
                              					inventor in accordance with <b><a href="mpep-9020-appx-r.html#d0e329661">37 CFR 1.497(a)</a></b> and (b). If
                              					the basic national fee and copy of the international application has been
                              					received by the expiration of 30 months from the priority date, but the required
                              					oath or declaration has not been filed, the Office will send applicant a
                              					Notification of Missing Requirements (Form PCT/DO/EO/905) setting a time period
                              					to correct any missing or defective requirements and to submit the surcharge fee
                              					required under 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329162">1.492</a></b> (h) unless previously
                              					paid. The time period is 32 months from the priority date or 2 months from the
                              					date of the notice, whichever expires later. The time period may be extended for
                              					up to five additional months as provided in <b><a href="mpep-9020-appx-r.html#d0e323655">37 CFR
                                    						1.136(a)</a></b> . Failure to timely file the required oath or
                              					declaration will result in abandonment of the application. 
                           </p>
                           <p id="d0e190927"> An oath or declaration
                              					satisfying the requirements of 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329661">1.497</a></b>
                              					(a)-(b) will be sufficient for the purposes of entering the U.S. national phase.
                              					However, if the oath or declaration fails to also comply with the additional
                              					requirements for oaths and declarations set forth in 37 CFR <b><a href="mpep-9020-appx-r.html#d0e319759">1.63</a></b> , applicants will need to submit a supplemental
                              					oath or declaration, or an application data sheet where permitted under 37 CFR
                              						<b><a href="mpep-9020-appx-r.html#d0e319759">1.63</a></b> (c), to correct the
                              					deficiency. See 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329661">1.497</a></b> (c). 
                           </p>
                           <p id="d0e190942"> In general, the requirement
                              					for an oath or declaration in compliance with 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329661">1.497</a></b> (a)-(b) will have been previously satisfied if a
                              					declaration in compliance with PCT Rule <b><a href="mpep-9025-appx-t.html#d0e366328">4.17</a></b> (iv)
                              					and executed by all the inventors was submitted within the time limits provided
                              					in PCT Rule <b><a href="mpep-9025-appx-t.html#d0e369930"> 26 ter .1
                                    					</a></b> in the international phase. However, if the inventorship was
                              					changed in the international application under PCT Rule <b><a href="mpep-9025-appx-t.html#d0e378036"> 92
                                    							bis</a></b> such that the inventorship identified in the PCT Rule
                              						<b><a href="mpep-9025-appx-t.html#d0e366328">4.17</a></b> (iv) declaration no
                              					longer corresponds to that of the international application (see 37 CFR
                              						<b><a href="mpep-9020-appx-r.html#d0e317666">1.41(a)(4)</a></b> ), then a new
                              					oath or declaration in accordance with 37&nbsp;CFR <b><a href="mpep-9020-appx-r.html#d0e329661">1.497</a></b> (a)-(b) will be required to enter the national
                              					stage. See 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329661">1.497</a></b> (f)(2). Similarly, a
                              					new oath or declaration in compliance with 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329661">1.497</a></b> (a)-(b) is required where the PCT Rule
                              						<b><a href="mpep-9025-appx-t.html#d0e366328">4.17(iv)</a></b> declaration was
                              					executed prior to a change in the international filing date pursuant to PCT Rule
                              						<b><a href="mpep-9025-appx-t.html#d0e368849">20.5</a></b> (c) . See 37 CFR
                              						<b><a href="mpep-9020-appx-r.html#d0e329661">1.497</a></b> (f)(1). In addition,
                              					where a priority claim has been corrected or added pursuant to PCT Rule
                              						<b><a href="mpep-9025-appx-t.html#d0e369679"> 26 bis</a></b> after execution of the PCT Rule <b><a href="mpep-9025-appx-t.html#d0e366328">4.17(iv)</a></b> declaration, then a supplemental oath or
                              					declaration, or an application data sheet, identifying the correct priority
                              					claim will be required. See 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329661">1.497</a></b> (g). 
                           </p>
                           <div class="Section">
                              <h2 class="section1" id="d0e191001">
                                 &nbsp;&nbsp;CORRECTION OF INVENTORSHIP
                              </h2>
                              <p id="d0e191005"> The inventorship of an
                                 						international application entering the national stage under 35 U.S.C.
                                 							<b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> is that
                                 						inventorship set forth in the international application, which includes any
                                 						changes effected under PCT Rule <b><a href="mpep-9025-appx-t.html#d0e378036"> 92 bis</a></b> . See 37 CFR <b><a href="mpep-9020-appx-r.html#d0e317666">1.41</a></b>
                                 						(a)(4). Accordingly, an oath or declaration that names an inventive entity
                                 						different than that set forth in the international application will not be
                                 						accepted for purposes of entering the U.S. national phase unless the
                                 						requirements under 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329661">1.497</a></b>
                                 						(d) are satisfied. These requirements include: (A) a statement from each
                                 						person being added as an inventor and from each person being deleted as an
                                 						inventor that any error in inventorship in the international application
                                 						occurred without deceptive intention on his or her part; (B) the processing
                                 						fee set forth in 37 CFR <b><a href="mpep-0010-title-page.html#d0e315199">1.17(i)</a></b> ; and (C) the
                                 						written consent of the assignee if an assignment has been executed by any of
                                 						the original named inventors (see 37 CFR <b><a href="mpep-9020-appx-r.html#d0e336732">3.73</a></b>
                                 						(b)). 
                              </p>
                              <p id="d0e191028"> If an inventor refuses
                                 						to execute the oath or declaration or cannot be found or reached after
                                 						diligent effort, applicant must file an oath or declaration and a petition
                                 						in accordance with <b><a href="mpep-9020-appx-r.html#d0e317892">37 CFR 1.47</a></b> . See 37
                                 						CFR <b><a href="mpep-9020-appx-r.html#d0e329661">1.497</a></b> (b) and MPEP §
                                 							<b><a href="s409.html#d0e23082">409.03</a></b> . Similarly, where
                                 						an inventor is deceased or legally incapacitated, an oath or declaration in
                                 						accordance with the provisions of <b><a href="mpep-9020-appx-r.html#d0e317787">37&nbsp;CFR
                                       							1.42</a></b> or <b><a href="mpep-9020-appx-r.html#d0e317800">1.43</a></b>
                                 						must be provided. See 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329661">1.497</a></b>
                                 						(b) and MPEP § <b><a href="s409.html#d0e22918">409.01</a></b> and §
                                 							<b><a href="s409.html#d0e23055">409.02</a></b> . 
                              </p>
                              <p id="d0e191055"> Where there has been no
                                 						change of inventorship but the name of an inventor indicated in the
                                 						international application during the international phase has changed such
                                 						that the inventor’s name is different from the corresponding name indicated
                                 						in an oath or declaration submitted under 37&nbsp;CFR <b><a href="mpep-9020-appx-r.html#d0e329661">1.497</a></b> , for example, on account of marriage, then a
                                 						petition under 37 CFR <b><a href="mpep-9020-appx-r.html#d0e324988">1.182</a></b> will be required
                                 						to accept the oath or declaration with the changed name. See MPEP §
                                 							<b><a href="mpep-0010-title-page.html#d0e41252">605.04</a></b> (c). However, where
                                 						the discrepancy between the name of the inventor indicated in the
                                 						international application during the international phase and the name of the
                                 						inventor as it appears in the oath or declaration submitted under 37 CFR
                                 							<b><a href="mpep-9020-appx-r.html#d0e329661">1.497</a></b> is the result of
                                 						a typographical or transliteration error, then a petition under 37 CFR
                                 							<b><a href="mpep-9020-appx-r.html#d0e324988">1.182</a></b> will not be
                                 						required. In such case, the Office should simply be notified of the error.
                                 						Similarly, a typographical or transliteration error in the name of an
                                 						inventor identified in a previously submitted oath or declaration may be
                                 						corrected by simply notifying the Office of the error. A new oath or
                                 						declaration is not required to correct such error. See MPEP §
                                 							<b><a href="mpep-0010-title-page.html#d0e4830">201.03</a></b> and §
                                 							<b><a href="mpep-0010-title-page.html#d0e41330">605.04</a></b> (g).
                                 					
                              </p>
                           </div>
                        </div>
                     </div>
                     <div class="Section">
                        <h1 class="page-title" id="d0e191079">1893.02
                           &nbsp;&nbsp;Abandonment [R-08.2012]
                        </h1>
                        <p id="d0e191083"> If the requirements for the
                           				submission of the basic national fee and a copy of the international application (if
                           				necessary) prior to the expiration of 30 months from the priority date are not
                           				satisfied, then the international application becomes abandoned as to the United
                           				States at thirty months from the priority date. 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329467">1.495</a></b> (h). If the requirements under 37 CFR
                           					<b><a href="mpep-9020-appx-r.html#d0e329467">1.495</a></b> (b) are timely met, but
                           				the requirements under 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329467">1.495</a></b> (c) for an English
                           				translation of the international application, oath/declaration, search fee,
                           				examination fee and application size fee are not met within a time period set in a
                           				notice provided by the Office, then the application will become abandoned upon
                           				expiration of the time period set in the notice. See 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329467">1.495</a></b> (c)(2) and <b><a href="mpep-9020-appx-r.html#d0e329467">1.495</a></b> (h) . 
                        </p>
                        <p id="d0e191106">Examiners and applicants should
                           				be aware that sometimes papers filed for the national stage are deficient and
                           				abandonment results. For example, if the fee submitted does not include at least the
                           				amount of the basic national fee that is due, the application becomes
                           				abandoned.
                        </p>
                        <p id="d0e191109"> Applicant may file a petition to
                           				revive an abandoned application in accordance with the provisions of
                           					<b><a href="mpep-9020-appx-r.html#d0e323800">37 CFR 1.137</a></b> . See
                           					<b><a href="s711.html#d0e81972">MPEP § 711.03(c)</a></b> . For applicant’s convenience,
                           				applicant may use either Form PTO/SB/61PCT (unavoidably abandoned application) or
                           				Form PTO/SB/64PCT (unintentionally abandoned application), as appropriate, for this
                           				purpose. These forms are available online at
                           				http://www.uspto.gov/web/forms/index.html#patent. 
                        </p>
                     </div>
                     <div class="Section">
                        <h1 class="page-title" id="d0e191121">1893.03
                           &nbsp;&nbsp;Prosecution of U.S. National Stage Applications Before the
                           				Examiner [R-08.2012]
                        </h1>
                        <div id="d0e191129" class="CFR">
                           <h4 class="CFR"><i>37&nbsp;C.F.R.&nbsp;1.496&nbsp;
                                 
                                 
                                 
                                 Examination of international applications in the
                                 					national stage.</i></h4>
                           <ul style="list-style-type: none;">
                              <li id="d0e191134" class="nobull">(a)  International
                                 								applications which have complied with the requirements of
                                 									<b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C. 371</a></b>
                                 								(c) will be taken up for action based on the date on which such
                                 								requirements were met. However, unless an express request for early
                                 								processing has been filed under <b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C.
                                       									371</a></b> (f), no action may be taken prior to one
                                 								month after entry into the national stage. 
                              </li>
                              <li id="d0e191144" class="nobull">(b)  National stage
                                 								applications having paid therein the search fee as set forth in §
                                 									<b><a href="mpep-9020-appx-r.html#d0e329162">1.492</a></b> (b)(1)
                                 								and the examination fee as set forth in § <b><a href="mpep-9020-appx-r.html#d0e329162">1.492</a></b> (c)(1) may be amended subsequent to
                                 								the date of entry into the national stage only to the extent
                                 								necessary to eliminate objections as to form or to cancel rejected
                                 								claims. Such national stage applications will be advanced out of
                                 								turn for examination. 
                              </li>
                           </ul>
                        </div>
                        <p id="d0e191154"> An international application
                           				which enters the national stage will be forwarded to the appropriate Technology
                           				Center (TC) for examination in turn based on the <b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C.
                                 					371(c)</a></b> date of the application. If an international
                           				preliminary examination report (IPER) prepared by the United States International
                           				Preliminary Examining Authority or a written opinion on the international
                           				application prepared by the United States International Searching Authority states
                           				that the criteria of novelty, inventive step (non-obviousness), and industrial
                           				applicability, as defined in PCT Article <b><a href="mpep-9025-appx-t.html#d0e364085">33</a></b> (1)-(4)
                           				have been satisfied for all of the claims presented in the application entering the
                           				national stage, the national stage search fee is reduced and the national stage
                           				examination fee is reduced. See 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329162">1.492</a></b> (b)(1)
                           				and 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329162">1.492</a></b> (c)(1). Such applications
                           				may be amended only to the extent necessary to eliminate objections as to form or
                           				cancel rejected claims, and they will be advanced out of turn for examination. See
                           				MPEP § <b><a href="s708.html#d0e76229">708</a></b> for a discussion of the order
                           				of examination of applications by examiners. 
                        </p>
                        <p id="d0e191172">Once the national stage
                           				application has been taken up by the examiner, prosecution proceeds in the same
                           				manner as for a domestic application with the exceptions that:
                        </p>
                        <div id="d0e191175" class="List">
                           <ul style="list-style-type: none;">
                              <li id="d0e191176" class="nobull">(A)  the international
                                 							filing date (or, if appropriate, the priority date) is the date to keep
                                 							in mind when searching the prior art; and 
                              </li>
                              <li id="d0e191184" class="nobull">(B)  unity of invention
                                 							proceeds as under 37 CFR <b><a href="mpep-9020-appx-r.html#d0e328679">1.475</a></b> . 
                              </li>
                           </ul>
                        </div>
                        <div class="Section">
                           <h1 class="page-title" id="d0e191193">1893.03(a) &nbsp;&nbsp;How To Identify That an Application Is a U.S. National
                              					Stage Application
                           </h1>
                           <p id="d0e191201"> Applicant’s initially
                              					deposited application must be clearly identified as a submission to enter the
                              					national stage under <b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C. 371.</a></b> See
                              						<b><a href="mpep-9020-appx-r.html#d0e329467">37&nbsp;CFR 1.495(g)</a></b> .
                              					Otherwise, unless the submission is clearly identified as a submission pursuant
                              					to 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e303482">154</a></b> (d)(4) for the purpose
                              					of obtaining provisional rights, the application will be treated as an
                              					application filed under <b><a href="mpep-9015-appx-l.html#d0e302673">35&nbsp;U.S.C. 111(a)</a></b> . See 37
                              					CFR <b><a href="mpep-9020-appx-r.html#d0e327633">1.417</a></b> . 
                           </p>
                           <p id="d0e191219"> That is, if applicant wishes
                              					the application to be treated as a filing under <b><a href="mpep-9015-appx-l.html#d0e302673">35 U.S.C.
                                    						111(a)</a></b> , applicant’s originally filed application papers
                              					need indicate simply that the papers are for a new U.S. patent application. If,
                              					however, applicant is submitting papers for entry into the national stage of a
                              					PCT application, or to establish an effective date for provisional rights
                              					resulting from the filing of a PCT application under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e303482">154(d)</a></b> , applicant must so state. Applicants seeking to
                              					enter the national stage are advised to use transmittal Form PTO-1390, as this
                              					form clearly indicates that the submission is under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> . Examination of the original application papers
                              					occurs in either the Office of Initial Patent Examination or in the National
                              					Stage Processing Division of the Office of PCT Operations where it is determined
                              					whether applicant has asked that the papers be treated as a submission to enter
                              					the national stage under <b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C. 371</a></b> . If the
                              					application is accepted for entry into the&nbsp;national stage, the National Stage
                              					Processing Division will mail Form PCT/DO/EO/903 indicating acceptance of the
                              					application as a national stage submission under <b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C.
                                    						371</a></b> . PALM records will indicate that the application is
                              					a national stage entry of the PCT application (e.g., under “Continuity Data”).
                              					Initially, the examiner should check the application file for the presence of
                              					Form PCT/DO/EO/903 and review the PALM Bib-data sheet for an indication that the
                              					application is a national stage entry (371) of the PCT application. 
                           </p>
                           <p id="d0e191249"> If neither of these
                              					indications are present the application may, in the absence of evidence to the
                              					contrary (there is an indication in the originally filed application papers that
                              					processing as a national stage is desired), be treated as a filing under
                              						<b><a href="mpep-9015-appx-l.html#d0e302673">35 U.S.C. 111(a)</a></b> . Thus, if
                              					both indications are present, the application should be treated as a submission
                              					under <b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C. 371</a></b> . The
                              					examiner is advised to consult the Office of PCT Legal Administration if he or
                              					she has any question as to whether the application should be treated under 35
                              					U.S.C. <b><a href="mpep-9015-appx-l.html#d0e302673">111</a></b> (a) or
                              						<b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> . 
                           </p>
                           <p id="d0e191268"> In accordance with the
                              					notice at 1077 O.G. 13 (14 April 1987), if the applicant files a U.S. national
                              					application and clearly identifies in the accompanying oath or declaration the
                              					specification to which it is directed by referring to a particular international
                              					application by PCT Application Number and International Filing Date and that he
                              					or she is executing the declaration as, and seeking a U.S. Patent as, the
                              					inventor of the invention described in the identified international application,
                              					then the application will be accepted as submitted under <b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C.
                                    						371</a></b> . Merely claiming priority of an international (PCT)
                              					application in an oath or declaration will not serve to indicate a submission
                              					under <b><a href="mpep-9015-appx-l.html#d0e307164">35&nbsp;U.S.C. 371</a></b> . Also, if
                              					there are any conflicting instructions as to whether the filing is under
                              						<b><a href="mpep-9015-appx-l.html#d0e302673">35 U.S.C. 111(a)</a></b> or
                              						<b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C. 371</a></b> , the
                              					application will be accepted as filed under <b><a href="mpep-9015-appx-l.html#d0e302673">35&nbsp;U.S.C.
                                    						111(a)</a></b> . A conflicting instruction will be present, for
                              					example, where applicant includes in the initial submission under 35 U.S.C.
                              						<b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> , a “Utility Patent
                              					Application Transmittal” (Form PTO/SB/05) or includes a benefit claim under 35
                              					U.S.C. <b><a href="mpep-0010-title-page.html#d0e303023">120</a></b> to the international
                              					application. Applications that have been processed under 35 U.S.C.
                              						<b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> and later found by the
                              					examiner to contain conflicting instructions should be forwarded to the Office
                              					of PCT Legal Administration for resolution. 
                           </p>
                           <div class="figure" id="d0e191295"><img src="graphics/1893_03a-1.png" alt="Form PCT Filed Under 35 USC 371" width="747" height="894"></div>
                           <div class="figure" id="d0e191301"><img src="graphics/1893_03a-2.png" alt="Form PCT/DO/DO/903. Notification of Acceptance of Application Under 35 U.S.C. and 37 CFR 1.494 or 1.495" width="747" height="906"></div>
                        </div>
                        <div class="Section">
                           <h1 class="page-title" id="d0e191308">1893.03(b) &nbsp;&nbsp;The Filing Date of a U.S. National Stage
                              					Application
                           </h1>
                           <p id="d0e191316"> An international application
                              					designating the U.S. has two stages (international and national) with the filing
                              					date being the same in both stages. Often the date of entry into the national
                              					stage is confused with the filing date. It should be borne in mind that the
                              					filing date of the international stage application is also the filing date for
                              					the national stage application. Specifically, <b><a href="mpep-9015-appx-l.html#d0e306994">35 U.S.C.
                                    						363</a></b> provides that 
                           </p>
                           <blockquote id="d0e191322">
                              <p id="d0e191323"> An international
                                 						application designating the United States shall have the effect, from its
                                 						international filing date under Article 11 of the treaty, of a national
                                 						application for patent regularly filed in the Patent and Trademark Office
                                 						except as otherwise provided in section <b><a href="mpep-9015-appx-l.html#d0e302383">102(e)</a></b>
                                 						of this title. 
                              </p>
                           </blockquote>
                           <p id="d0e191329"> Similarly, <b><a href="mpep-9025-appx-t.html#d0e363237">PCT Article
                                    						11(3)</a></b> provides that 
                           </p>
                           <blockquote id="d0e191335">
                              <p id="d0e191336">...an international
                                 						filing date shall have the effect of a regular national application in each
                                 						designated State as of the international filing date, which date shall be
                                 						considered to be the actual filing date in each designated
                                 						State.
                              </p>
                           </blockquote>
                           <p id="d0e191339"><b><a href="mpep-9020-appx-r.html#d0e329630">37 CFR 1.496(a)</a></b> , first
                              					sentence, reads “International applications which have complied with the
                              					requirements of <b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C. 371(c)</a></b> will be
                              					taken up for action based on the date on which such requirements were met.”
                              					Thus, when the file wrapper label or PALM bib-data sheet and filing receipt are
                              					printed, the information is read from the PALM data base and the information
                              					printed in the filing date box is the date of receipt of 35 U.S.C.
                              						<b><a href="mpep-9015-appx-l.html#d0e307164">371(c)(1), (c)(2) and
                                    						(c)(4)</a></b> requirements rather than the actual international
                              					filing date. 
                           </p>
                           <p id="d0e191350"> The NOTIFICATION OF
                              					ACCEPTANCE OF APPLICATION UNDER 35&nbsp;U.S.C. 371 AND 37&nbsp;CFR <b><a href="mpep-9020-appx-r.html#d0e329467">1.495</a></b> (Form PCT/DO/EO/903), a copy of which is
                              					reproduced in MPEP §&nbsp; <b><a href="s1893.html#d0e191193">1893.03(a)</a></b> , indicates the
                              					date of receipt of the 35&nbsp;U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b>
                              					(c)(1), (c)(2), and (c)(4) requirements, and it also indicates the date of
                              					completion of all 35&nbsp;U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> requirements, which is
                              					further explained below. Filing receipts are mailed concurrently with the
                              					mailing of the Form PCT/DO/EO/903. 
                           </p>
                           <p id="d0e191368"> The 
                              "Application Filing Date"
                              
                              
                               field formerly
                              					displayed in PAIR was changed to 
                              " Filing or
                              							<b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> (c) Date
                              					"
                              
                              
                               to clearly indicate that for international applications
                              					that enter the national stage under 35&nbsp;U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> , the information displayed in this field is the
                              					date of receipt of the 35&nbsp;U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b>
                              					(c)(1), (c)(2) and (c)(4) requirements. Applicants are quite often confused as
                              					to the true filing date and will ask for corrected filing receipts thinking that
                              					the information thereon is wrong. This explanation should offer some clarity.
                              					For most legal purposes, the filing date is the PCT international filing date.
                              					Exceptions to this general rule include the following: 
                           </p>
                           <div id="d0e191386" class="List">
                              <ul style="list-style-type: none;">
                                 <li id="d0e191387" class="nobull">(A)  Availability as
                                    								a prior art reference under former 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e302383">102</a></b> (e) (prior to the amendment by the
                                    								American Inventors Protection Act of 1999 (AIPA) (Pub. L. 106-113,
                                    								113 Stat. 1501 (1999)). If a U.S. patent issued from an
                                    								international application filed prior to November 29, 2000, the
                                    								international application was not considered to have been filed in
                                    								the United States for prior art purposes under 35&nbsp;U.S.C. 102(e) and
                                    								PCT Article <b><a href="mpep-9025-appx-t.html#d0e365412">64</a></b> (4)(a) until
                                    								the date the application fulfilled the requirements of 35&nbsp;U.S.C.
                                    									<b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> (c) (1),
                                    								(2), and (4). 
                                 </li>
                                 <li id="d0e191400" class="nobull">(B)  Availability as
                                    								a prior art reference under 35&nbsp;U.S.C. <b><a href="mpep-9015-appx-l.html#d0e302383">102</a></b> (e) as amended by the AIPA, and further
                                    								amended by the Intellectual Property and High Technology Technical
                                    								Amendments Act of 2002 (Pub. L. 107-273, 116 Stat. 1758 (2002)). If
                                    								an international application was filed on or after November 29,
                                    								2000, but did not designate the U.S. or was not published in English
                                    								under PCT Article <b><a href="mpep-9025-appx-t.html#d0e363622">21</a></b> (2), the international filing date is
                                    									<span class="Underline">not</span> treated as a U.S.
                                    								filing date for prior art purposes under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e302383">102</a></b> (e). See MPEP § <b><a href="s706.html#d0e58605">706.02</a></b> (a) and § <b><a href="s2136.html#d0e205924">2136.03</a></b> . 
                                 </li>
                                 <li id="d0e191422" class="nobull">(C)  Patent term
                                    								adjustment under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e303482">154</a></b> (b)(1)(B) and 37 CFR <b><a href="mpep-9020-appx-r.html#d0e331127">1.702</a></b> (b) when the USPTO has failed to issue
                                    								a patent within three years of the “actual filing date” of an
                                    								application. In this situation, the “actual filing date” is the date
                                    								the national stage commenced under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> (b) or (f). See MPEP §
                                    									<b><a href="s2730.html#d0e272521">2730</a></b> .
                                    							
                                 </li>
                              </ul>
                           </div>
                           <p id="d0e191438"> The “Date of Completion of
                              					all 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> Requirements” included
                              					on the NOTIFICATION OF ACCEPTANCE OF APPLICATION UNDER 35&nbsp;U.S.C.
                              						<b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> AND 37 CFR
                              						<b><a href="mpep-9020-appx-r.html#d0e329467">1.495</a></b> (Form PCT/DO/EO/903)
                              					is relevant for purposes of patent term adjustment under 35 U.S.C.
                              						<b><a href="mpep-9015-appx-l.html#d0e303482">154</a></b> (b)(1)(A)(i)(II) and 37
                              					CFR <b><a href="mpep-9020-appx-r.html#d0e331127">1.702</a></b> (a)(1) when the USPTO
                              					has failed to mail at least one of a notification under 35 U.S.C.
                              						<b><a href="mpep-9015-appx-l.html#d0e303187">132</a></b> or a notice of
                              					allowance under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e303440">151</a></b> not later than fourteen
                              					months after the date on which the requirements under 35 U.S.C.
                              						<b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> were fulfilled. This
                              					date is the latest of: 
                           </p>
                           <div id="d0e191465" class="List">
                              <ul style="list-style-type: none;">
                                 <li id="d0e191466" class="nobull">(A) the date of
                                    								submission of the basic national fee;
                                 </li>
                                 <li id="d0e191470" class="nobull">(B) the date of
                                    								submission or communication of the copy of the international
                                    								application;
                                 </li>
                                 <li id="d0e191474" class="nobull">(C) the date of
                                    								submission of the translation of the international application if
                                    								the international application is not in the English
                                    								language;
                                 </li>
                                 <li id="d0e191478" class="nobull">(D)  the date of
                                    								submission of an oath or declaration of the inventor in compliance
                                    								with 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> (c)(4) (see
                                    								37 CFR <b><a href="mpep-9020-appx-r.html#d0e329661">1.497</a></b> (c) for
                                    								an explanation of when an oath or declaration will be accepted as
                                    								complying with 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> (c)(4)); 
                                 </li>
                                 <li id="d0e191491" class="nobull">(E)  the earlier of
                                    								30 months from the priority date or the date of request for early
                                    								processing under 35&nbsp;U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> (f) if requested prior to 30 months from
                                    								the priority date (Form PCT/DO/EO/903 will indicate the date early
                                    								processing was requested); 
                                 </li>
                                 <li id="d0e191498" class="nobull">(F) if a request for
                                    								early processing has not been requested prior to 30 months from the
                                    								priority date, the date of submission of any translation of the
                                    								annexes to the international preliminary examination report if the
                                    								translation of the annexes are filed within the time period set in a
                                    								Notification of Missing Requirements (Form PCT/DO/EO/905) requiring
                                    								either an English translation of the international application or an
                                    								oath or declaration; and
                                 </li>
                                 <li id="d0e191502" class="nobull">(G) the date of
                                    								submission of any surcharge for submitting the oath or declaration
                                    								later than 30 months from the priority date.
                                 </li>
                              </ul>
                           </div>
                        </div>
                        <div class="Section">
                           <h1 class="page-title" id="d0e191506">1893.03(c) &nbsp;&nbsp;The Priority Date, Priority Claim, and Priority Papers
                              					for a U.S. National Stage Application
                           </h1>
                           <p id="d0e191518"> A U.S. national stage
                              					application may be entitled to: (A) a right of priority under 35 U.S.C.
                              						<b><a href="mpep-9015-appx-l.html#d0e302921">119</a></b> (a) and
                              						<b><a href="mpep-9015-appx-l.html#d0e307034">365</a></b> (b) based on a prior
                              					foreign application or international application designating at least one
                              					country other than the United States; and (B) the benefit of an earlier filed
                              					U.S. national application or international application designating the United
                              					States pursuant to 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e302921">119</a></b> (e) or
                              					35 U.S.C. <b><a href="mpep-0010-title-page.html#d0e303023">120</a></b> and <b><a href="mpep-9015-appx-l.html#d0e307034">365</a></b> (c). 
                           </p>
                           <div class="Section">
                              <h2 class="section1" id="d0e191536">I.
                                 &nbsp;&nbsp; RIGHT OF PRIORITY UNDER 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e302921">119</a></b> (a) and <b><a href="mpep-9015-appx-l.html#d0e307034">365</a></b>
                                 						(b) 
                              </h2>
                              <p id="d0e191546"> Pursuant to 35 U.S.C.
                                 							<b><a href="mpep-9015-appx-l.html#d0e307034">365</a></b> (b) a U.S. national
                                 						stage application shall be entitled to a right of priority based on a prior
                                 						foreign application or international application designating at least one
                                 						country other than the United States in accordance with the conditions and
                                 						requirements of 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e302921">119</a></b>
                                 						(a) and the treaty and the PCT regulations. See in particular PCT Article
                                 							<b><a href="mpep-9025-appx-t.html#d0e363180">8</a></b> and PCT Rules
                                 							<b><a href="mpep-9025-appx-t.html#d0e366150">4.10</a></b> and
                                 							<b><a href="mpep-9025-appx-t.html#d0e369679"> 26 bis</a></b> . To obtain priority in the U.S. national stage
                                 						application to such applications, the priority must have been timely claimed
                                 						in the international stage of the international application. See 37 CFR
                                 							<b><a href="mpep-9020-appx-r.html#d0e319215">1.55</a></b> (a)(1)(ii). If
                                 						priority was properly claimed in the international stage of the
                                 						international application, the claim for priority is acknowledged (subject
                                 						to the paragraph below) and the national stage application file is checked
                                 						to see if the file contains a copy of the certified copy of the priority
                                 						document submitted to the International Bureau. 
                              </p>
                              <p id="d0e191573"> International
                                 						applications filed on or after April 1, 2007 are subject to amended PCT
                                 						Rules permitting restoration of a right of priority. See MPEP §
                                 							<b><a href="s1828.html#d0e170589">1828.01</a></b> . Consequently,
                                 						international applications filed on or after April 1, 2007 may claim
                                 						priority to a foreign application filed more than 12 months before the
                                 						filing date of the international application. While such priority claims are
                                 						permitted in the international stage, the right of priority will not be
                                 						effective in the U.S. national stage, as 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e302921">119</a></b> (a) does not permit a priority period that
                                 						exceeds 12 months. 
                              </p>
                              <p id="d0e191584"> If the priority claim in
                                 						the national stage application is to an application, the priority of which
                                 						was not claimed in the international stage of the international application,
                                 						the claim for priority must be denied for failing to meet the requirements
                                 						of the Patent Cooperation Treaty, specifically <b><a href="mpep-9025-appx-t.html#d0e366150">PCT
                                       							Rule 4.10</a></b> . 
                              </p>
                              <p id="d0e191590"> For a comparison with
                                 							<b><a href="mpep-9015-appx-l.html#d0e302921">35 U.S.C. 119(a)</a></b> -(d)
                                 						priority claims in a national application filed under <b><a href="mpep-9015-appx-l.html#d0e302673">35&nbsp;U.S.C. 111(a),</a></b> see <b><a href="s1895.html#d0e192774">MPEP §
                                       							1895.01</a></b> . 
                              </p>
                           </div>
                           <div class="Section">
                              <h2 class="section1" id="d0e191602">II.
                                 &nbsp;&nbsp;THE CERTIFIED COPY
                              </h2>
                              <p id="d0e191606"> The requirement in
                                 							<b><a href="mpep-9025-appx-t.html#d0e368311">PCT Rule 17</a></b> for a
                                 						certified copy of the foreign priority application is normally fulfilled by
                                 						applicant providing a certified copy to the receiving Office or to the
                                 						International Bureau or by applicant requesting the receiving Office to
                                 						prepare and transmit the priority document to the International Bureau if
                                 						the receiving Office issued the priority document. Pursuant to PCT Rule
                                 							<b><a href="mpep-9025-appx-t.html#d0e368318">17.1</a></b> (a)-(b), applicant
                                 						must submit the certified copy, or request the receiving Office to prepare
                                 						and transmit the certified copy, within 16 months from the priority date.
                                 						Where applicant has complied with PCT Rule <b><a href="mpep-9025-appx-t.html#d0e368311">17</a></b> , the International Bureau will forward a copy of
                                 						the certified priority document to each Designated Office that has requested
                                 						such document with an indication that the priority document was submitted in
                                 						compliance with the rule and the date the document was received by the
                                 						International Bureau. This indication may be in the form of either a cover
                                 						sheet attached to the copy of the priority document or a WIPO stamp on the
                                 						face of the certified copy. The U.S. Patent and Trademark Office, as a
                                 						Designated Office, will normally request the International Bureau to furnish
                                 						the copy of the certified priority document upon receipt of applicant’s
                                 						submission under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> to
                                 						enter the U.S. national phase. The copy from the International Bureau is
                                 						placed in the U.S. national stage file. The copy of the priority document
                                 						received from the International Bureau with either of the indications above
                                 						is acceptable to establish that applicant has filed a certified copy of the
                                 						priority document. The examiner should acknowledge in the next Office action
                                 						that the copy of the certified copy of the foreign priority document has
                                 						been received in the national stage application from the International
                                 						Bureau. 
                              </p>
                              <p id="d0e191631"> On the following pages,
                                 						note the examples of acceptable indications in the form of: 
                              </p>
                              <div id="d0e191636" class="List">
                                 <ul style="list-style-type: none;">
                                    <li id="d0e191637" class="nobull">(A)  a cover
                                       									sheet indicating receipt by the International Bureau on 02
                                       									February 2006 and compliance with PCT Rule <b><a href="mpep-9025-appx-t.html#d0e368311">17</a></b> in the
                                       									“Remark” section; and 
                                    </li>
                                    <li id="d0e191644" class="nobull">(B)  the stamp
                                       									(box) in the upper right hand section indicating receipt by the
                                       									International Bureau (WIPO) on 30 December 2002 and the stamped
                                       									indication 
                                       "PRIORITY
                                       										DOCUMENT SUBMITTED OR TRANSMITTED IN COMPLIANCE WITH RULE
                                       										17.1(a) OR (b)."
                                       
                                       
                                       
                                    </li>
                                 </ul>
                              </div>
                              <div class="figure" id="d0e191654"><img src="graphics/189303c-1.png" alt="Document made available under the Patent Cooperation Treaty (PCT)" width="756" height="871"></div>
                              <div class="figure" id="d0e191657"><img src="graphics/189303c-2.png" alt="Japan Patent Office.  This is to certify that the annexed is a true copy of the following applications as filed with this office." width="758" height="1011"></div>
                              <div class="figure" id="d0e191660"><img src="graphics/189303c-3.png" alt="Japan Patent Office. Page 2. List of Applicant(s) " width="758" height="856"></div>
                              <div class="figure" id="d0e191665"><img src="graphics/189303c-4.png" alt="Australia. PCT/AU02/01658 Priority Document Submitted or Transmitted in Compliance with Rule 17.1(a) or (b). Patent Office Canberra" width="762" height="909"></div>
                              <p id="d0e191668"> If the International
                                 						Bureau is unable to forward a copy of the certified priority document to the
                                 						U.S. Patent and Trademark Office because applicant failed to comply with PCT
                                 						Rule <b><a href="mpep-9025-appx-t.html#d0e368311">17</a></b> (a)-(b), then
                                 						applicant will have to provide a certified copy of the priority document (or
                                 						have the priority document furnished in accordance with 37 CFR
                                 							<b><a href="mpep-9020-appx-r.html#d0e319215">1.55</a></b> (d)) during the
                                 						national stage to fulfill the requirement of <b><a href="mpep-9020-appx-r.html#d0e319215">37 CFR
                                       							1.55(a)(2)</a></b> . 
                              </p>
                           </div>
                           <div class="Section">
                              <h2 class="section1" id="d0e191684">III.
                                 &nbsp;&nbsp; BENEFIT CLAIM UNDER 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e302921">119</a></b> (e), OR <b><a href="mpep-0010-title-page.html#d0e303023">120</a></b>
                                 						AND <b><a href="mpep-9015-appx-l.html#d0e307034">365</a></b> (c) 
                              </h2>
                              <p id="d0e191697"> A national stage
                                 						application may include a benefit claim under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e302921">119</a></b> (e), or <b><a href="mpep-0010-title-page.html#d0e303023">120</a></b>
                                 						and <b><a href="mpep-9015-appx-l.html#d0e307034">365</a></b> (c) to a prior U.S.
                                 						national application or under 35 U.S.C. <b><a href="mpep-0010-title-page.html#d0e303023">120</a></b>
                                 						and <b><a href="mpep-9015-appx-l.html#d0e307034">365</a></b> (c) to a prior
                                 						international application designating the U.S. The conditions for according
                                 						benefit under <b><a href="mpep-0010-title-page.html#d0e303023">35 U.S.C. 120</a></b> are as
                                 						described in <b><a href="mpep-0010-title-page.html#d0e9852">MPEP §&nbsp;201.07</a></b> ,
                                 							<b><a href="mpep-0010-title-page.html#d0e9971">§ 201.08</a></b> , and
                                 							<b><a href="mpep-0010-title-page.html#d0e10254">§&nbsp;201.11</a></b> and are similar
                                 						regardless of whether the U.S. national application is a national stage
                                 						application submitted under <b><a href="mpep-9015-appx-l.html#d0e307164">35&nbsp;U.S.C.
                                       							371</a></b> or a national application filed under
                                 							<b><a href="mpep-9015-appx-l.html#d0e302673">35&nbsp;U.S.C. 111(a).</a></b></p>
                              <p id="d0e191732"> The conditions for
                                 						according benefit under 35&nbsp;&nbsp;U.S.C. <b><a href="mpep-9015-appx-l.html#d0e302921">119</a></b>
                                 						(e) are also similar for national stage applications and applications filed
                                 						under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e302673">111</a></b> (a), and the
                                 						conditions are described in MPEP §&nbsp; <b><a href="mpep-0010-title-page.html#d0e10254">201.11</a></b> . 
                              </p>
                              <p id="d0e191744"> In order for a national
                                 						stage application (of international application “X”) to obtain benefit under
                                 						35&nbsp;U.S.C. <b><a href="mpep-9015-appx-l.html#d0e302921">119(e)</a></b> of a prior U.S.
                                 						provisional application, the national stage application must comply with the
                                 						requirements set forth in 37 CFR <b><a href="mpep-9020-appx-r.html#d0e320662">1.78(a)(4)</a></b> through 37 CFR <b><a href="mpep-9020-appx-r.html#d0e320662">1.78(a)(6)</a></b> . Public Law 106-113 amended 35 U.S.C.
                                 							<b><a href="mpep-9015-appx-l.html#d0e302921">119(e)</a></b> to eliminate the
                                 						copendency requirement for a nonprovisional application claiming benefit of
                                 						a provisional application. 35&nbsp;U.S.C. <b><a href="mpep-9015-appx-l.html#d0e302921">119(e)(2)</a></b> as amended became effective on November
                                 						29, 1999 and applies to provisional applications filed on or after June 8,
                                 						1995. 37 CFR <b><a href="mpep-9020-appx-r.html#d0e320662">1.78(a)(4)</a></b> requires
                                 						that the prior provisional application must be entitled to a filing date as
                                 						set forth in 37&nbsp;CFR <b><a href="mpep-9020-appx-r.html#d0e318681">1.53(c)</a></b> , and the basic
                                 						filing fee set forth in 37&nbsp;CFR <b><a href="mpep-9020-appx-r.html#d0e314702">1.16(d)</a></b> must be paid on the provisional application
                                 						within the time period set forth in 37 CFR <b><a href="mpep-9020-appx-r.html#d0e318681">1.53(g)</a></b> . Additionally, the provisional application
                                 						must name as an inventor at least one inventor named in the later filed
                                 						international application “X” and disclose the named inventor’s invention
                                 						claimed in at least one claim of the national stage application in the
                                 						manner provided by the first paragraph of 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e302824">112</a></b> . The national stage application must contain a
                                 						reference to the provisional application (either in an application data
                                 						sheet (37 CFR <b><a href="mpep-9020-appx-r.html#d0e320348">1.76</a></b> ) or in the first
                                 						sentence(s) of the specification), identifying it as a provisional
                                 						application, and including the provisional application number (series code
                                 						and serial number). The required reference to the earlier provisional
                                 						application must be submitted within the time period provided by 37 CFR
                                 							<b><a href="mpep-9020-appx-r.html#d0e320662">1.78(a)(5)(ii)</a></b> . This
                                 						time period is not extendable. However, if the entire delay, between the
                                 						date the claim was due under 37&nbsp;CFR <b><a href="mpep-9020-appx-r.html#d0e320662">1.78</a></b>
                                 						(a)(5)(ii) and the date the claim was filed, was unintentional, a petition
                                 						under 37 CFR <b><a href="mpep-9020-appx-r.html#d0e320662">1.78</a></b> (a)(6) may be
                                 						filed to accept the delayed claim. If the provisional application was filed
                                 						in a language other than English, an English-language translation of the
                                 						non-English language provisional application and a statement that the
                                 						translation is accurate will be required. See MPEP § <b><a href="mpep-0010-title-page.html#d0e10254">201.11</a></b> , subsection VI. If the translation and
                                 						statement that the translation is accurate were not filed in the provisional
                                 						application or in the later-filed national stage application before November
                                 						25, 2005, applicant will be notified and given a period of time within which
                                 						to file an English-language translation and a statement that the translation
                                 						is accurate in the provisional application, and a reply in the national
                                 						stage application that the translation and statement were filed in the
                                 						provisional application. Failure to timely reply to such a notice will
                                 						result in abandonment of the national stage application. See 37 CFR
                                 							<b><a href="mpep-9020-appx-r.html#d0e320662">1.78(a)(5)(iv)</a></b> . 
                              </p>
                              <p id="d0e191795"> In order for a national
                                 						stage application (of international application “X”) to obtain benefit under
                                 						35&nbsp;U.S.C. <b><a href="mpep-0010-title-page.html#d0e303023">120</a></b> and
                                 							<b><a href="mpep-9015-appx-l.html#d0e307034">365(c)</a></b> of a prior filed
                                 						copending nonprovisional application or prior filed copending international
                                 						application designating the United States of America, the national stage
                                 						application must comply with the requirements set forth in 37 CFR 1.78(a)(1)
                                 						through 37 CFR <b><a href="mpep-9020-appx-r.html#d0e320662">1.78(a)(3)</a></b> . The prior
                                 						nonprovisional application or international application must name as an
                                 						inventor at least one inventor named in the later filed international
                                 						application “X” and disclose the named inventor’s invention claimed in at
                                 						least one claim of the national stage application in the manner provided by
                                 						the first paragraph of 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e302824">112</a></b> .
                                 						The national stage application must contain a reference to the prior
                                 						nonprovisional or international application (either in an application data
                                 						sheet (37&nbsp;CFR <b><a href="mpep-9020-appx-r.html#d0e320348">1.76</a></b> ) or in the first
                                 						sentence(s) of the specification), identifying it by application number
                                 						(series code and serial number) or international application number and
                                 						international filing date and indicating the relationship of the
                                 						applications. The required reference to the earlier filed application must
                                 						be submitted within the later of four months from the date on which the
                                 						national stage commenced under 35&nbsp;U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b>
                                 						(b) or (f) or sixteen months from the filing date of the prior-filed
                                 						application. This time period is not extendable and failure to timely submit
                                 						the required reference to the earlier application will be considered a
                                 						waiver of any benefit under 35 U.S.C. <b><a href="mpep-0010-title-page.html#d0e303023">120</a></b> ,
                                 							<b><a href="mpep-9015-appx-l.html#d0e303040">121</a></b> , or
                                 							<b><a href="mpep-9015-appx-l.html#d0e307034">365</a></b> (c) to such
                                 						prior-filed application. See 37 CFR <b><a href="mpep-9020-appx-r.html#d0e320662">1.78</a></b>
                                 						(a)(2)(ii). However, if the entire delay, between the date the claim was due
                                 						under 37 CFR <b><a href="mpep-9020-appx-r.html#d0e320662">1.78</a></b> (a)(2)(ii) and the
                                 						date the claim was filed, was unintentional, a petition under 37 CFR
                                 						1.78(a)(3) may be filed to accept the delayed claim. 
                              </p>
                              <p id="d0e191831">A prior filed
                                 						nonprovisional application is copending with the national stage application
                                 						if the prior U.S. national application was pending on the international
                                 						filing date of the national stage application.
                              </p>
                              <p id="d0e191834"> A prior-filed
                                 						international application designating the United States of America is
                                 						copending with the national stage application if the prior international
                                 						application was not abandoned or withdrawn , either generally or as to the
                                 						United States, on the international filing date of the national stage
                                 						application. 
                              </p>
                              <p id="d0e191850"> Note: a national stage
                                 						application submitted under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b>
                                 						may not claim benefit of the filing date of the international application of
                                 						which it is the national stage since its filing date is the international
                                 						filing date of the international application. See also <b><a href="s1893.html#d0e191308">MPEP
                                       							§&nbsp;1893.03(b)</a></b> . Stated differently, since the
                                 						international application is not an earlier application (it has the same
                                 						filing date as the national stage), a benefit claim under 35 U.S.C.
                                 							<b><a href="mpep-0010-title-page.html#d0e303023">120</a></b> in the national
                                 						stage to the international application is inappropriate and may result in
                                 						the submission being treated as an application filed under 35 U.S.C.
                                 							<b><a href="mpep-9015-appx-l.html#d0e302673">111</a></b> (a). See MPEP §&nbsp;
                                 							<b><a href="s1893.html#d0e191193">1893.03(a)</a></b> . Accordingly,
                                 						it is not necessary for the applicant to amend the first sentence(s) of the
                                 						specification to reference the international application number that was
                                 						used to identify the application during international processing of the
                                 						application by the international authorities prior to commencement of the
                                 						national stage. 
                              </p>
                              <p id="d0e191873"> For a comparison with
                                 							<b><a href="mpep-0010-title-page.html#d0e303023">35 U.S.C. 120</a></b> benefit
                                 						claims in a national application filed under <b><a href="mpep-9015-appx-l.html#d0e302673">35
                                       							U.S.C. 111(a)</a></b> , see <b><a href="s1895.html#d0e192715">MPEP §
                                       							1895</a></b> . 
                              </p>
                           </div>
                        </div>
                        <div class="Section">
                           <h1 class="page-title" id="d0e191885">1893.03(d) &nbsp;&nbsp;Unity of Invention</h1>
                           <div id="d0e191889" class="CFR">
                              <h4 class="CFR"><i>37&nbsp;C.F.R.&nbsp;1.499&nbsp;
                                    
                                    
                                    
                                    Unity of invention during the national
                                    						stage</i></h4>
                              <p id="d0e191893"> If the examiner finds
                                 						that a national stage application lacks unity of invention under
                                 							<b><a href="mpep-9020-appx-r.html#d0e328679">§ 1.475</a></b> , the examiner
                                 						may in an Office action require the applicant in the response to that action
                                 						to elect the invention to which the claims shall be restricted. Such
                                 						requirement may be made before any action on the merits but may be made at
                                 						any time before the final action at the discretion of the examiner. Review
                                 						of any such requirement is provided under <b><a href="mpep-9020-appx-r.html#d0e324130">§§&nbsp;1.143</a></b> and <b><a href="mpep-9020-appx-r.html#d0e324143">1.144</a></b>
                                 						. 
                              </p>
                           </div>
                           <p id="d0e191905"><b><a href="mpep-9025-appx-t.html#d0e367565">PCT Rule 13</a></b> was amended
                              					effective July 1, 1992. <b><a href="mpep-9020-appx-r.html#d0e328679">37&nbsp;CFR 1.475</a></b> was amended
                              					effective May 1, 1993 to correspond to <b><a href="mpep-9025-appx-t.html#d0e367565">PCT Rule
                                    						13</a></b> . 
                           </p>
                           <p id="d0e191916"> Examiners are reminded that
                              					unity of invention (not restriction practice pursuant to 37 CFR
                              						<b><a href="mpep-9020-appx-r.html#d0e324081">1.141</a></b> - <b><a href="mpep-9020-appx-r.html#d0e324178">1.146</a></b> ) is applicable in international applications
                              					(both Chapter I and II) and in national stage applications submitted under 35
                              					U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> . Restriction practice
                              					in accordance with 37 CFR <b><a href="mpep-9020-appx-r.html#d0e324081">1.141</a></b> - <b><a href="mpep-9020-appx-r.html#d0e324178">1.146</a></b> continues to apply to U.S. national applications
                              					filed under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e302673">111(a)</a></b> , even if the
                              					application filed under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e302673">111(a)</a></b>
                              					claims benefit under 35 U.S.C. <b><a href="mpep-0010-title-page.html#d0e303023">120</a></b> and
                              						<b><a href="mpep-9015-appx-l.html#d0e307034">365</a></b> (c) to an earlier
                              					international application designating the United States or to an earlier U.S.
                              					national stage application submitted under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> . 
                           </p>
                           <p id="d0e191949"> The sections of the MPEP
                              					relating to double patenting rejections (MPEP § <b><a href="s804.html#d0e98894">804</a></b> ), election and reply by applicant (MPEP §
                              						<b><a href="s818.html#d0e107481">818)</a></b> , and rejoinder of
                              					nonelected inventions (MPEP § <b><a href="s821.html#d0e108548">821.04</a></b> )
                              					generally also apply to national stage applications submitted under 35 U.S.C.
                              						<b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> . See MPEP §
                              						<b><a href="s823.html#d0e109969">823</a></b> . 
                           </p>
                           <p id="d0e191969">When making a lack of unity
                              					of invention requirement, the examiner must (1) list the different groups of
                              					claims and (2) explain why each group lacks unity with each other group (i.e.,
                              					why there is no single general inventive concept) specifically describing the
                              					unique special technical feature in each group.
                           </p>
                           <p id="d0e191972"> The principles of unity of
                              					invention are used to determine the types of claimed subject matter and the
                              					combinations of claims to different categories of invention that are permitted
                              					to be included in a single international or national stage patent application.
                              					See MPEP § <b><a href="s1850.html#d0e175250">1850</a></b> for a detailed discussion
                              					of Unity of Invention. The basic principle is that an application should relate
                              					to only one invention or, if there is more than one invention, that applicant
                              					would have a right to include in a single application only those inventions
                              					which are so linked as to form a single general inventive concept. 
                           </p>
                           <p id="d0e191978">A group of inventions is
                              					considered linked to form a single general inventive concept where there is a
                              					technical relationship among the inventions that involves at least one common or
                              					corresponding special technical feature. The expression special technical
                              					features is defined as meaning those technical features that define the
                              					contribution which each claimed invention, considered as a whole, makes over the
                              					prior art. For example, a corresponding technical feature is exemplified by a
                              					key defined by certain claimed structural characteristics which correspond to
                              					the claimed features of a lock to be used with the claimed key. Note also the
                              					examples contained in Chapter 10 of the International Search and Preliminary
                              					Examination Guidelines which can be obtained from WIPO’s web site
                              					(www.wipo.int/pct/en/texts/gdlines.htm).
                           </p>
                           <p id="d0e191981">A process is “specially
                              					adapted” for the manufacture of a product if the claimed process inherently
                              					produces the claimed product with the technical relationship being present
                              					between the claimed process and the claimed product. The expression “specially
                              					adapted” does not imply that the product could not also be manufactured by a
                              					different process.
                           </p>
                           <p id="d0e191984">An apparatus or means is
                              					specifically designed for carrying out the process when the apparatus or means
                              					is suitable for carrying out the process with the technical relationship being
                              					present between the claimed apparatus or means and the claimed process. The
                              					expression specifically designed does not imply that the apparatus or means
                              					could not be used for carrying out another process, nor does it imply that the
                              					process could not be carried out using an alternative apparatus or
                              					means.
                           </p>
                           <p id="d0e191987">Note: the determination
                              					regarding unity of invention is made without regard to whether a group of
                              					inventions is claimed in separate claims or as alternatives within a single
                              					claim. The basic criteria for unity of invention are the same, regardless of the
                              					manner in which applicant chooses to draft a claim or claims.
                           </p>
                           <p id="d0e191990"> If an examiner (1)
                              					determines that the claims lack unity of invention and (2) requires election of
                              					a single invention, when all of the claims drawn to the elected invention are
                              					allowable (i.e., meet the requirements of 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e302376">101</a></b> , <b><a href="mpep-9015-appx-l.html#d0e302383">102</a></b> ,
                              						<b><a href="mpep-9015-appx-l.html#d0e302450">103</a></b> and <b><a href="mpep-9015-appx-l.html#d0e302824">112</a></b> ), the nonelected invention(s) should be considered
                              					for rejoinder. Any nonelected product claim that requires all the limitations of
                              					an allowable product claim, and any nonelected process claim that requires all
                              					the limitations of an allowable process claim, should be rejoined. See MPEP §
                              						<b><a href="s821.html#d0e108548">821.04</a></b> . Any nonelected
                              					processes of making and/or using an allowable product should be considered for
                              					rejoinder . The examiner should notify applicants of potential rejoinder of
                              					non-elected process claims by placing form paragraph <b><a href="#fp8.21.04">8.21.04</a></b> at
                              					the end of any lack of unity determination made between a product and a process
                              					of making the product or between a product and a process of using the product. 
                           </p>
                           <div class="Section">
                              <h2 class="section1" id="d0e192017">
                                 &nbsp;&nbsp;FORM PARAGRAPHS FOR LACK OF UNITY IN NATIONAL STAGE
                                 						APPLICATIONS
                              </h2>
                              <div class="formPara"><a name="fp18.18"></a><h1 class="page-title">¶ 18.18
                                    &nbsp;&nbsp;
                                    Heading for Lack of Unity Action in National Stage Applications Submitted Under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> (Including Species)
                                 </h1>REQUIREMENT FOR UNITY OF INVENTION
                                 <p id="fp-pt-d794e18">As provided in 37 CFR <b><a href="mpep-9020-appx-r.html#d0e328679">1.475(</a></b>a), a national stage application shall relate to one invention only or to a group of inventions so linked as to form a single
                                    general inventive concept (“requirement of unity of invention”). Where a group of inventions is claimed in a national stage
                                    application, the requirement of unity of invention shall be fulfilled only when there is a technical relationship among those
                                    inventions involving one or more of the same or corresponding special technical features. The expression “special technical
                                    features” shall mean those technical features that define a contribution which each of the claimed inventions, considered
                                    as a whole, makes over the prior art.
                                 </p>
                                 <p id="fp-pt-d794e24">The determination whether a group of inventions is so linked as to form a single general inventive concept shall be made without
                                    regard to whether the inventions are claimed in separate claims or as alternatives within a single claim.  See 37 CFR 1.475(e).
                                 </p>When Claims Are Directed to Multiple Categories of Inventions:
                                 <p id="fp-pt-d794e34">As provided in 37 CFR <b><a href="mpep-9020-appx-r.html#d0e328679">1.475</a></b>(b), a national stage application containing claims to different categories of invention will be considered to have unity
                                    of invention if the claims are drawn only to one of the following combinations of categories:
                                 </p>
                                 <div id="" class="List">
                                    <ul style="list-style-type: none;">
                                       <li id="fp-lil-d794e43" class="nobull">(1) A product and a process specially adapted for the manufacture of said product; or</li>
                                       <li id="fp-lil-d794e52" class="nobull">(2) A product and process of use of said product; or</li>
                                       <li id="fp-lil-d794e61" class="nobull">(3) A product, a process specially adapted for the manufacture of the said product, and a use of the said product; or</li>
                                       <li id="fp-lil-d794e70" class="nobull">(4) A process and an apparatus or means specifically designed for carrying out the said process; or</li>
                                       <li id="fp-lil-d794e79" class="nobull">(5) A product, a process specially adapted for the manufacture of the said product, and an apparatus or means specifically designed
                                          for carrying out the said process.
                                       </li>
                                    </ul>
                                 </div>
                                 <p id="fp-pt-d794e90">Otherwise, unity of invention might not be present.  See 37 CFR <b><a href="mpep-9020-appx-r.html#d0e328679">1.475</a></b>(c).
                                 </p>
                                 <h3>Examiner Note:</h3>  <ul style="list-style-type: none;">
                                 <li class="nobull">1. Begin all Lack of Unity actions in national stage applications submitted under 35 U.S.C. 371 (including species) with this
                                    heading.
                                 </li>
                                 <li class="nobull">2. Follow with form paragraph <b><a href="#fp18.19">18.19</a></b> or <b><a href="#fp18.20">18.20</a></b>, as appropriate.
                                 </li>
                                 <li class="nobull">3. For lack of unity during the international phase, use form paragraph 18.05 instead of this form paragraph.</li>  </ul>
                              </div>
                              <div class="formPara"><a name="fp18.19"></a><h1 class="page-title">¶ 18.19
                                    &nbsp;&nbsp;
                                    Restriction Requirement in National Stage Applications Submitted Under <b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C. 371</a></b></h1>
                                 <p id="fp-pt-d795e12">Restriction is required under <b><a href="mpep-9015-appx-l.html#d0e303040">35 U.S.C. 121</a></b> and <b><a href="mpep-9015-appx-l.html#d0e307259">372</a></b>.
                                 </p>
                                 <p id="fp-pt-d795e21">This application contains the following inventions or groups of inventions which are not so linked as to form a single general
                                    inventive concept under <b><a href="mpep-9025-appx-t.html#d0e367572">PCT Rule 13.1</a></b>.
                                 </p>
                                 <p id="fp-pt-d795e27">In accordance with <b><a href="mpep-9020-appx-r.html#d0e329844">37 CFR 1.499</a></b>, applicant is required, in reply to this action, to elect a single invention to which the claims must be restricted.
                                 </p>
                                 <h3>Examiner Note:</h3>  <ul style="list-style-type: none;">
                                 <li class="nobull">1. This form paragraph is to be used when making a restriction requirement in a national stage application submitted under <b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C. 371</a></b>.
                                 </li>
                                 <li class="nobull">2. This form paragraph is to be followed by form paragraphs <b><a href="#fp18.06">18.06</a></b> - <b><a href="#fp18.06.02">18.06.02</a></b>, as appropriate, and by form paragraphs <b><a href="#fp18.07">18.07</a></b> - <b><a href="#fp18.07.02">18.07.02</a></b>, as appropriate.
                                 </li>
                                 <li class="nobull">3. All restriction requirements between a product/apparatus and a process of making the product/apparatus or between a product
                                    and a process of using the product should be followed by form paragraph 8.21.04 to notify the applicant that if all product/apparatus
                                    claims are found allowable, process claims that require all the limitations of the patentable product/apparatus should be
                                    considered for rejoinder.
                                 </li>
                                 <li class="nobull">4. When all of the claims directed to the elected invention are in condition for allowance, the propriety of the restriction
                                    requirement should be reconsidered to verify that the non-elected claims do not share a same or corresponding technical feature
                                    with the allowable claims.
                                 </li>  </ul>
                              </div>
                              <div class="formPara"><a name="fp8.21.04"></a><h1 class="page-title">¶ 8.21.04
                                    &nbsp;&nbsp;
                                    Notice of Potential Rejoinder of Process Claims
                                 </h1>
                                 <p id="fp-pt-d437e9">The examiner has required restriction between product and process claims. Where applicant elects claims directed to the product/apparatus,
                                    and all product/apparatus claims are subsequently found allowable, withdrawn process claims that include all the limitations
                                    of the allowable product/apparatus claims should be considered for rejoinder. All claims directed to a nonelected process
                                    invention must include all the limitations of an allowable product/apparatus claim for that process invention to be rejoined.
                                 </p>
                                 <p id="fp-pt-d437e15">In the event of rejoinder, the requirement for restriction between the product/apparatus claims and the rejoined process claims
                                    will be withdrawn, and the rejoined process claims will be fully examined for patentability in accordance with <b><a href="mpep-9020-appx-r.html#d0e322124">37 CFR 1.104</a></b>. Thus, to be allowable, the rejoined claims must meet all criteria for patentability including the requirements of <b><a href="mpep-9015-appx-l.html#d0e302376">35 U.S.C. 101</a></b>, <b><a href="mpep-9015-appx-l.html#d0e302383">102</a></b>, <b><a href="mpep-9015-appx-l.html#d0e302450">103 </a></b>and <b><a href="mpep-9015-appx-l.html#d0e302824">112</a></b>. Until all claims to the elected product/apparatus are found allowable, an otherwise proper restriction requirement between
                                    product/apparatus claims and process claims may be maintained. Withdrawn process claims that
                                    are not commensurate in scope with an allowable product/apparatus claim will not be rejoined. See <b><a href="s821.html#d0e108548">MPEP § 821.04</a></b>. Additionally, in order for rejoinder to occur, applicant is advised that the process claims should be amended during prosecution
                                    to require the limitations of the product/apparatus claims. <b id="">Failure to do so may result in no rejoinder. </b>Further, note that the prohibition against double patenting rejections of <b><a href="mpep-9015-appx-l.html#d0e303040">35 U.S.C. 121</a></b> does not apply where the restriction requirement is withdrawn by the examiner before the patent issues. See <b><a href="s804.html#d0e101210">MPEP § 804.01.</a></b></p>
                                 <h3>Examiner Note:</h3>
                                 <p id="fp-pt-d437e48">This form paragraph should appear at the end of any requirement for restriction between a process and a product/apparatus
                                    for practicing the process (see form paragraph <b><a href="#fp8.17">8.17</a></b>), a product/apparatus and a process of making the product/apparatus (see form paragraph <b><a href="#fp8.18">8.18</a></b>) or between a product/apparatus and a process of using the product/apparatus (see form paragraph <b><a href="#fp8.20">8.20</a></b>). See <b><a href="s821.html#d0e108548">MPEP § 821.04</a></b> for rejoinder practice.
                                 </p>
                              </div>
                              <div class="formPara"><a name="fp18.20"></a><h1 class="page-title">¶ 18.20
                                    &nbsp;&nbsp;
                                    Election of Species in National Stage Applications Submitted Under <b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C. 371</a></b></h1>
                                 <p id="fp-pt-d796e12">This application contains claims directed to more than one species of the generic invention. These species are deemed to lack
                                    unity of invention because they are not so linked as to form a single general inventive concept under <b><a href="mpep-9025-appx-t.html#d0e367572">PCT Rule 13.1</a></b>. 
                                 </p>
                                 <p id="fp-pt-d796e18">The species are as follows: </p>
                                 <p id="fp-pt-d796e21"><b id="">[1]</b></p>
                                 <p id="fp-pt-d796e28">Applicant is required, in reply to this action, to elect a single species to which the claims shall be restricted if no generic
                                    claim is finally held to be allowable. The reply must also identify the claims readable on the elected species, including
                                    any claims subsequently added. An argument that a claim is allowable or that all claims are generic is considered non-responsive
                                    unless accompanied by an election.
                                 </p>
                                 <p id="fp-pt-d796e31">Upon the allowance of a generic claim, applicant will be entitled to consideration of claims to additional species which are
                                    written in dependent form or otherwise require all the limitations of an allowed generic claim. Currently, the following claim(s)
                                    are generic:  <b id="">[2]</b>.
                                 </p>
                                 <h3>Examiner Note:</h3>  <ul style="list-style-type: none;">
                                 <li class="nobull">1. This form paragraph is to be used when making an election of species requirement in a national stage application submitted
                                    under <b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C. 371</a></b>.
                                 </li>
                                 <li class="nobull">2. In bracket 1, identify the species from which an election is to be made.</li>
                                 <li class="nobull">3. In bracket 2, identify each generic claim by number or insert the word --NONE--.</li>
                                 <li class="nobull">4. This form paragraph is to be followed by form
                                    paragraphs <b><a href="#fp18.07">18.07</a></b> - <b><a href="#fp18.07.03">18.07.03</a></b>, as
                                    appropriate.
                                 </li>  </ul>
                              </div>
                              <div class="formPara"><a name="fp18.21"></a><h1 class="page-title">¶ 18.21
                                    &nbsp;&nbsp;
                                    Election by Original Presentation in National Stage Applications Submitted Under <b><a href="mpep-9015-appx-l.html#d0e307164">35&nbsp;U.S.C. 371</a></b></h1>
                                 <p id="fp-pt-d797e12">Newly submitted claim <b id="">[1]</b> directed to an invention that lacks unity with the invention originally claimed for the following reasons: <b id="">[2]</b></p>
                                 <p id="fp-pt-d797e21">Since applicant has received an action on the merits for the originally presented invention, this invention has been constructively
                                    elected by original presentation for prosecution on the merits. Accordingly, claim <b id="">[3]</b> withdrawn from consideration as being directed to a nonelected invention. See <b><a href="mpep-9020-appx-r.html#d0e324111">37 CFR 1.142(b)</a></b> and <b><a href="s821.html#d0e108405">MPEP § 821.03</a></b>.
                                 </p>
                              </div>
                              <div class="formPara"><a name="fp18.22"></a><h1 class="page-title">¶ 18.22
                                    &nbsp;&nbsp;
                                    Requirement for Election and Means for Traversal in National Stage Applications Submitted Under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b></h1>
                                 <p id="fp-pt-d798e12">Applicant is advised that the reply to this requirement to be complete must include (i) an election of a species or invention
                                    to be examined even though the requirement may be traversed (37 CFR <b><a href="mpep-9020-appx-r.html#d0e324130">1.143</a></b>) and (ii) identification of the claims encompassing the elected invention. 
                                 </p>
                                 <p id="fp-pt-d798e18">The election of an invention or species may be made with or without traverse. To preserve a right to petition, the election
                                    must be made with traverse. If the reply does not distinctly and specifically point out supposed errors in the restriction
                                    requirement, the election shall be treated as an election without traverse.  Traversal must be presented at the time of election
                                    in order to be considered timely.  Failure to timely traverse the requirement will result in the loss of right to petition
                                    under 37 CFR 1.144.  If claims are added after the election, applicant must indicate which of these claims are readable on
                                    the elected invention or species.
                                 </p>
                                 <p id="fp-pt-d798e21">Should applicant traverse on the ground that the inventions have unity of invention (<b><a href="mpep-9020-appx-r.html#d0e328679">37 CFR 1.475</a></b>(a)), applicant must provide reasons in support thereof.  Applicant may submit evidence or identify such evidence now of record
                                    showing the inventions to be obvious variants or clearly admit on the record that this is the case.  Where such evidence or
                                    admission is provided by applicant, if the examiner finds one of the inventions unpatentable over the prior art, the evidence
                                    or admission may be used in a rejection under <b><a href="mpep-9015-appx-l.html#d0e302450">35 U.S.C. 103</a></b>(a) of the other invention.  
                                 </p>
                                 <h3>Examiner Note:</h3>  <ul style="list-style-type: none;">
                                 <li class="nobull">1. This form paragraph should be used when requiring restriction (including an election of species) in an application that entered
                                    the national stage under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b>.
                                 </li>
                                 <li class="nobull">2. This form paragraph should follow form paragraph <b><a href="#fp8.23.01">8.23.01</a></b> when a telephone call was made that did not result in an election being made.
                                 </li>  </ul>
                              </div>
                           </div>
                        </div>
                        <div class="Section">
                           <h1 class="page-title" id="d0e192440">1893.03(e) &nbsp;&nbsp;Documents Received from the International Bureau and
                              					Placed in a U.S. National Stage Application File
                           </h1>
                           <p id="d0e192444">The national stage
                              					application includes documents forwarded by the International Bureau and
                              					submissions from applicant. Some of the documents from the International Bureau
                              					are identified in this section with a brief note as to their importance to the
                              					national stage application. The examiner should review each such document and
                              					the important aspect indicated.
                           </p>
                           <div class="Section">
                              <h2 class="section1" id="d0e192447">I.
                                 &nbsp;&nbsp;THE PUBLICATION OF THE INTERNATIONAL
                                 						APPLICATION
                              </h2>
                              <p id="d0e192451">The publication of the
                                 						international application includes
                              </p>
                              <div id="d0e192454" class="List">
                                 <ul style="list-style-type: none;">
                                    <li id="d0e192455" class="nobull">(A) a cover page
                                       									with the applicant/inventor data, the application data
                                       									(application number, filing date, etc.) and the Abstract (and,
                                       									if appropriate, a figure of drawing),
                                    </li>
                                    <li id="d0e192459" class="nobull">(B) the
                                       									description, claims and drawing parts of the international
                                       									application, and
                                    </li>
                                    <li id="d0e192463" class="nobull">(C) the search
                                       									report (Form PCT/ISA/210), if available.
                                    </li>
                                 </ul>
                              </div>
                              <p id="d0e192467"> The cover page is
                                 						important as a source of the correct application data, most importantly the
                                 						filing date and priority date accorded to the international application. If
                                 						the international application is published in English, the Office will use
                                 						the description, claims, abstract and drawings as published in the pamphlet
                                 						for the U.S. national stage application under <b><a href="mpep-9015-appx-l.html#d0e307164">35&nbsp;U.S.C. 371</a></b> . The description, claims and drawing
                                 						parts of the international application reflect the application subject
                                 						matter on the international filing date and are important for comparison
                                 						with any amendments to check for new matter. The search report reflects the
                                 						International Searching Authority’s opinion regarding the prior art. 
                              </p>
                              <p id="d0e192473"> The abstract is
                                 						reproduced on the cover page of the publication, even though it appears on a
                                 						separate sheet of the international application in accordance with PCT Rule
                                 							<b><a href="mpep-9025-appx-t.html#d0e366919">11.4</a></b> (a). The
                                 						requirement of 37 CFR <b><a href="mpep-9020-appx-r.html#d0e318327">1.52(b)</a></b> that the
                                 						abstract “commence on a separate physical sheet or electronic page” does not
                                 						apply to the copy of the published international application communicated to
                                 						the designated Offices by the International Bureau under PCT Article
                                 							<b><a href="mpep-9025-appx-t.html#d0e363585">20</a></b> . Accordingly, it is
                                 						improper for the examiner of the U.S. national stage application to require
                                 						the applicant to provide an abstract commencing on a separate sheet if the
                                 						abstract does not appear on a separate sheet in the publication of the
                                 						international application. Unless the abstract is properly amended under the
                                 						U.S. rules during national stage processing, the abstract that appears on
                                 						the cover page of the published international application will be the
                                 						abstract published by the USPTO under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e303054">122</a></b> (b) and in any U.S. patent issuing from the
                                 						application. 
                              </p>
                           </div>
                           <div class="Section">
                              <h2 class="section1" id="d0e192488">II.
                                 &nbsp;&nbsp;THE INTERNATIONAL PRELIMINARY EXAMINATION REPORT AND
                                 						THE INTERNATIONAL PRELIMINARY REPORT ON PATENTABILITY (CHAPTER I AND
                                 						II)
                              </h2>
                              <p id="d0e192496">When an international
                                 						preliminary examination is performed by an International Preliminary
                                 						Examining Authority (IPEA), an international preliminary examination report
                                 						(IPER) is prepared on Form PCT/IPEA/409 by the IPEA and sent to the elected
                                 						Offices. This report reflects the IPEA’s non-binding opinion regarding
                                 						novelty, inventive step and industrial applicability. For international
                                 						applications filed on or after January 1, 2004, the IPER bears the title
                                 						“International Preliminary Report on Patentability (Chapter II of the Patent
                                 						Cooperation Treaty)”.
                              </p>
                              <p id="d0e192499">If the applicant did not
                                 						timely file a demand for international preliminary examination with the
                                 						IPEA, and the international application has a filing date on or after
                                 						January 1, 2004, then an “International Preliminary Report on Patentability
                                 						(Chapter I of the Patent Cooperation Treaty)” reflecting the International
                                 						Searching Authority’s (ISA’s) non-binding opinion regarding novelty,
                                 						inventive step and industrial applicability is sent to the designated
                                 						Offices.
                              </p>
                              <p id="d0e192502">The examiner may adopt
                                 						any portion or all of the report on patentability of the IPEA or ISA upon
                                 						consideration in the national stage so long as it is consistent with U.S.
                                 						practice. The first Office action on the merits should indicate the report
                                 						on patentability of the IPEA or ISA has been considered by the examiner. The
                                 						indication may be a mere acknowledgement.
                              </p>
                              <p id="d0e192505"> The IPER may include
                                 						annexes, i.e., amendments to the international application that were made
                                 						during the international phase. See MPEP § <b><a href="s1893.html#d0e190008">1893.01(a)(3)</a></b> . These annexes will be placed in
                                 						the U.S. national stage application file. Consequently, if the international
                                 						application has been extensively amended during the international stage,
                                 						there may be a number of different copies of the description, claims and
                                 						drawings present in the national stage application file. The IPER may be
                                 						consulted in Box No. I “Basis of the report” to determine what pages the
                                 						report was based upon. Using the IPER as a roadmap of what happened during
                                 						Chapter II examination will help determine which version should be examined. 
                              </p>
                              <p id="d0e192511"> Original sheets,
                                 						substitute sheets, rectified sheets , and sheets that were incorporated by
                                 						reference and included as part of the application examined under Chapter II
                                 						are listed in the IPER as pages “originally filed/furnished.” Replacement
                                 						sheets showing amendments made under PCT Article <b><a href="mpep-9025-appx-t.html#d0e363565">19</a></b> or <b><a href="mpep-9025-appx-t.html#d0e364117">34</a></b> and
                                 						considered during Chapter II are also listed. See MPEP §
                                 							<b><a href="s1879.html#d0e188136">1879</a></b> . If the IPER was
                                 						established in a language other than English, the International Bureau will
                                 						translate the IPER into English. However, the International Bureau will not
                                 						translate the annexes to the IPER into English. Unless proper and timely
                                 						translations are furnished by the applicant, foreign language annexes will
                                 						be considered canceled. See MPEP § <b><a href="s1893.html#d0e190008">1893.01(a)(3)</a></b> . All replacement sheets in the
                                 						international application are marked with the international application
                                 						number and the date of receipt in the upper right-hand corner. Replacement
                                 						sheets that contain changes in format only and are accepted by the receiving
                                 						Office are marked as “SUBSTITUTE SHEET” at the bottom of the page.
                                 						Replacement sheets that contain a rectification of an obvious error or
                                 						mistake and are accepted by either the ISA or the IPEA are marked as
                                 						“RECTIFIED SHEET (RULE 91)” at the bottom of the page. Sheets that were
                                 						incorporated by reference and accepted by the receiving Office are marked as
                                 						“INCORPORATED BY REFERENCE (RULE 20.6). Additionally, replacement sheets to
                                 						the claims submitted to the International Bureau as Article
                                 							<b><a href="mpep-9025-appx-t.html#d0e363565">19</a></b> Amendments will be
                                 						marked as “AMENDED SHEET (Article <b><a href="mpep-9025-appx-t.html#d0e363565">19</a></b> )”
                                 						at the bottom of the page. Furthermore, replacement sheets to the
                                 						description, claims and drawings submitted to the IPEA as Article
                                 							<b><a href="mpep-9025-appx-t.html#d0e364117">34</a></b> Amendments will be
                                 						marked as “AMENDED SHEET” at the bottom of the page. The IPER will indicate
                                 						in “Box No. I Basis of the Report” that replacement sheets submitted under
                                 						either PCT Article <b><a href="mpep-9025-appx-t.html#d0e363565">19</a></b> or <b><a href="mpep-9025-appx-t.html#d0e364117">34</a></b> have been considered and will indicate the date
                                 						they were received and the replacement sheets will be annexed to the IPER.
                                 						The NOTIFICATION OF ACCEPTANCE OF APPLICATION UNDER <b><a href="mpep-9015-appx-l.html#d0e307164">35
                                       							U.S.C. 371</a></b> AND 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329467">1.495</a></b> (Form PCT/DO/EO/903) should also be consulted,
                                 						as it will indicate if the annexes or their translation have not been
                                 						entered. A sample copy of the form has been reproduced at the end of MPEP §&nbsp;
                                 							<b><a href="s1893.html#d0e191193">1893.03(a)</a></b> . Additionally,
                                 						if the annexes have been entered, the National Stage Processing Division of
                                 						the Office of PCT Operations will write in pencil on any original sheet(s)
                                 						or translations thereof that were replaced, “Replaced by Article
                                 							<b><a href="mpep-9025-appx-t.html#d0e364117">34</a></b> Amendment” and on
                                 						the amended sheet(s) or translations thereof,” Article <b><a href="mpep-9025-appx-t.html#d0e364117">34</a></b> .” 
                              </p>
                           </div>
                           <div class="Section">
                              <h2 class="section1" id="d0e192575">III.
                                 &nbsp;&nbsp;THE PRIORITY DOCUMENT
                              </h2>
                              <p id="d0e192579"> See the discussion in
                                 							<b><a href="s1893.html#d0e191506">MPEP § 1893.03(c)</a></b> .
                                 					
                              </p>
                           </div>
                           <div class="Section">
                              <h2 class="section1" id="d0e192585">IV.
                                 &nbsp;&nbsp;NOTIFICATION OF WITHDRAWAL
                              </h2>
                              <p id="d0e192589"> If the national stage
                                 						application papers include an indication that the international application
                                 						or US designation has been withdrawn, then the application should be brought
                                 						to the attention of the Office of PCT Legal Administration to determine
                                 						whether the withdrawal occurred prior to completion of the requirements
                                 						under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> (c). If the
                                 						withdrawal occurred prior to completion of the requirements under 35 U.S.C.
                                 							<b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> (c), then entry
                                 						into the U.S. national stage is prohibited. See 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307064">366</a></b> . The indication of withdrawal may appear on a
                                 						Notification of Withdrawal (PCT/IB/307 or PCT/RO/136), a Notification that
                                 						International Application Considered to Be Withdrawn (Form PCT/RO/117), or
                                 						other notification. 
                              </p>
                           </div>
                           <div class="Section">
                              <h1 class="page-title" id="d0e192601">1893.03(e)(1) &nbsp;&nbsp;Title of the Invention [R-08.2012]</h1>
                              <p id="d0e192605"> In the absence of an
                                 						application data sheet (37 CFR <b><a href="mpep-9020-appx-r.html#d0e320348">1.76</a></b> )
                                 						or preliminary amendment changing the title, the Office will use the title
                                 						of the invention that appears on the first page of the description of the
                                 						published international application (if published under PCT Article
                                 							<b><a href="mpep-9025-appx-t.html#d0e363622">21</a></b> in English) or the
                                 						title that appears on the first page of the description of the English
                                 						translation of the international application (if not published under PCT
                                 						Article <b><a href="mpep-9025-appx-t.html#d0e363622">21</a></b> in English) in
                                 						preparing the official filing receipt. If the title does not appear on the
                                 						first page of the description, and an application data sheet or preliminary
                                 						amendment changing the title has not been furnished, then the title will be
                                 						taken from the cover page of the published international application. If
                                 						applicant furnishes an application data sheet or preliminary amendment
                                 						changing the title, the Office will use the title as indicated in such
                                 						document in preparing the official filing receipt. If applicant submits both
                                 						an application data sheet and a preliminary amendment, the later filed
                                 						document will govern. See 37 CFR <b><a href="mpep-9020-appx-r.html#d0e320348">1.76</a></b>
                                 						(d)(1). An application data sheet will govern over a concurrently filed
                                 						preliminary amendment. See 37 CFR <b><a href="mpep-9020-appx-r.html#d0e320348">1.76</a></b>
                                 						(d)(2). 
                              </p>
                           </div>
                        </div>
                        <div class="Section">
                           <h1 class="page-title" id="d0e192624">1893.03(f) &nbsp;&nbsp;Drawings and PCT Rule 11</h1>
                           <p id="d0e192628"> The drawings for the
                              					national stage application must comply with <b><a href="mpep-9025-appx-t.html#d0e366850">PCT Rule
                                    						11</a></b> . The USPTO may not impose requirements beyond those
                              					imposed by the Patent Cooperation Treaty (e.g., <b><a href="mpep-9025-appx-t.html#d0e366850">PCT Rule
                                    						11</a></b> ). However, the examiner does have the authority to
                              					require new drawings if the drawings were published without meeting all
                              					requirements under the PCT for drawings. 
                           </p>
                        </div>
                        <div class="Section">
                           <h1 class="page-title" id="d0e192639">1893.03(g) &nbsp;&nbsp;Information Disclosure Statement in a National Stage
                              					Application
                           </h1>
                           <p id="d0e192647"> An extensive discussion of
                              					Information Disclosure Statement practice is to be found in
                              						<b><a href="s609.html#d0e52594">MPEP § 609</a></b> . Although not
                              					specifically stated therein, the duty to disclose information material to
                              					patentability as defined in <b><a href="mpep-9020-appx-r.html#d0e319407">37 CFR 1.56</a></b> is placed on
                              					individuals associated with the filing and prosecution of a national stage
                              					application in the same manner as for a domestic national application. The
                              					averment with respect to the duty under 37 CFR <b><a href="mpep-9020-appx-r.html#d0e319407">1.56</a></b> required under 37 CFR <b><a href="mpep-9020-appx-r.html#d0e319759">1.63</a></b> (b)(3) in an oath or declaration is applicable to
                              					oaths and declarations filed in U.S. national stage applications. See 37 CFR
                              						<b><a href="mpep-9020-appx-r.html#d0e329661">1.497</a></b> (c). 
                           </p>
                           <p id="d0e192665"> When an international
                              					application is filed under the Patent Cooperation Treaty (PCT), prior art
                              					documents may be cited by the examiner in the international search report and/or
                              					the international preliminary examination report. It is desirable for the U.S.
                              					examiner to consider the documents cited in the international application when
                              					examining the U.S. national stage application or when examining an application
                              					filed under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e302673">111</a></b> (a) which claims the
                              					benefit of the international application under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307034">365</a></b> (a) or (c). 
                           </p>
                           <p id="d0e192676"> When all the requirements
                              					for a national stage application have been completed, applicant is notified
                              					(Form PCT/DO/EO/903) of the acceptance of the application under
                              						<b><a href="mpep-9015-appx-l.html#d0e307164">35&nbsp;U.S.C. 371</a></b> , including
                              					an itemized list of the items received. The itemized list includes an indication
                              					of whether a copy of the international search report and copies of the
                              					references cited therein are present in the national stage file. The examiner
                              					will consider the documents cited in the international search report, without
                              					any further action by applicant under <b><a href="mpep-9020-appx-r.html#d0e321609">37 CFR
                                    						1.97</a></b> and <b><a href="mpep-9020-appx-r.html#d0e321738">1.98</a></b> ,
                              					when both the international search report and copies of the documents are
                              					indicated to be present in the national stage file. The examiner will note the
                              					consideration in the first Office action. There is no requirement that the
                              					examiners list the documents on a PTO-892 form. See form paragraphs
                              						<b><a href="#fp6.53">6.53</a></b> , <b><a href="#fp6.54">6.54</a></b> , and
                              						<b><a href="#fp6.55">6.55</a></b> (reproduced in MPEP §
                              						<b><a href="s609.html#d0e53418">609.03</a></b> ). Otherwise, applicant
                              					must follow the procedure set forth in <b><a href="mpep-9020-appx-r.html#d0e321609">37 CFR
                                    						1.97</a></b> and 1.98 in order to ensure that the examiner
                              					considers the documents cited in the international search report. 
                           </p>
                           <p id="d0e192706"> This practice applies only
                              					to documents cited in the international search report relative to a national
                              					stage application filed under <b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C.
                                    						371</a></b> . It does not apply to documents cited in an
                              					international preliminary examination report that are not cited in the search
                              					report. It does not apply to applications filed under <b><a href="mpep-9015-appx-l.html#d0e302673">35 U.S.C.
                                    						111(a)</a></b> claiming the benefit of an international
                              					application filing date. 
                           </p>
                        </div>
                     </div>
                     <p align="right"><a href="#top">[top]</a></p>
                  </div>
               </div>
               <div>
                  <h1 class="page-title">&nbsp;</h1>
               </div>  </div>
            </div>
         </div>
      </div>
      <div class="yui-b">
         <div id="aside">  <div id="rdms-sub-nav-container" xmlns:bf="http://www.uspto.gov/bf">
            <ul id="sub-nav">
               <li xmlns=""><a href="s1801.html">1801-Basic Patent Cooperation Treaty (PCT) Principles</a></li>
               <li xmlns=""><a href="s1802.html">1802-PCT Definitions</a></li>
               <li xmlns=""><a href="s1803.html">1803-Reservations Under the PCT Taken by the United States of America</a></li>
               <li xmlns=""><a href="s1804.html">1804-[Reserved]</a></li>
               <li xmlns=""><a href="s1805.html">1805-Where To File an International Application</a></li>
               <li xmlns=""><a href="s1806.html">1806-[Reserved]</a></li>
               <li xmlns=""><a href="s1807.html">1807-Agent or Common Representative and General Power of Attorney</a></li>
               <li xmlns=""><a href="s1808.html">1808-Change in or Revocation of the Appointment of an Agent or a Common Representative</a></li>
               <li xmlns=""><a href="s1809.html">1809-[Reserved]</a></li>
               <li xmlns=""><a href="s1810.html">1810-Filing Date Requirements</a></li>
               <li xmlns=""><a href="s1811.html">1811-[Reserved]</a></li>
               <li xmlns=""><a href="s1812.html">1812-Elements of the International Application</a></li>
               <li xmlns=""><a href="s1813 - 1816.html">1813 - 1816-[Reserved]</a></li>
               <li xmlns=""><a href="s1817.html">1817-PCT Member States</a><ul>
                     <li><a href="s1817.html#d0e167497">1817.01-Designation of States in International Applications Having an International Filing Date On or After January 1, 2004</a><ul style="list-style-type: none">
                           <li><a href="s1817.html#d0e167644">1817.01(a)-Designation of States and Precautionary Designations in International Applications Having an International Filing Date Before
                                 January 1, 2004</a></li>
                        </ul>
                     </li>
                     <li><a href="s1817.html#d0e167827">1817.02-Continuation or Continuation-in-Part Indication in the Request</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1818.html">1818-[Reserved]</a></li>
               <li xmlns=""><a href="s1819.html">1819-Earlier Search</a></li>
               <li xmlns=""><a href="s1820.html">1820-Signature of Applicant</a></li>
               <li xmlns=""><a href="s1821.html">1821-The Request</a></li>
               <li xmlns=""><a href="s1822.html">1822-[Reserved]</a></li>
               <li xmlns=""><a href="s1823.html">1823-The Description</a><ul>
                     <li><a href="s1823.html#d0e168618">1823.01-Reference to Deposited Biological Material</a></li>
                     <li><a href="s1823.html#d0e169024">1823.02-Nucleotide and/or Amino Acid Sequence Listings, and Tables Related to Sequence Listings</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1824.html">1824-The Claims</a></li>
               <li xmlns=""><a href="s1825.html">1825-The Drawings</a></li>
               <li xmlns=""><a href="s1826.html">1826-The Abstract</a></li>
               <li xmlns=""><a href="s1827.html">1827-Fees</a><ul>
                     <li><a href="s1827.html#d0e170417">1827.01-Refund of International Application Fees</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1828.html">1828-Priority Claim and Document</a><ul>
                     <li><a href="s1828.html#d0e170589">1828.01-Restoration of the Right of Priority</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1829.html">1829-[Reserved]</a></li>
               <li xmlns=""><a href="s1830.html">1830-International Application Transmittal Letter</a></li>
               <li xmlns=""><a href="s1831.html">1831-[Reserved]</a></li>
               <li xmlns=""><a href="s1832.html">1832-License Request for Foreign Filing Under the PCT</a></li>
               <li xmlns=""><a href="s1833.html">1833-[Reserved]</a></li>
               <li xmlns=""><a href="s1834.html">1834-Correspondence</a><ul>
                     <li><a href="s1834.html#d0e170909">1834.01-Use of Telegraph, Teleprinter, Facsimile Machine</a></li>
                     <li><a href="s1834.html#d0e170997">1834.02-Irregularities in the Mail Service</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1835.html">1835-[Reserved]</a></li>
               <li xmlns=""><a href="s1836.html">1836-Rectification of Obvious Mistakes</a></li>
               <li xmlns=""><a href="s1837-1839.html">1837-1839-[Reserved]</a></li>
               <li xmlns=""><a href="s1840.html">1840-The International Searching Authority</a><ul>
                     <li><a href="s1840.html#d0e171588">1840.01-The European Patent Office as an International Searching Authority</a></li>
                     <li><a href="s1840.html#d0e171975">1840.02-The Korean Intellectual Property Office as an International Searching Authority</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1841.html">1841-[Reserved]</a></li>
               <li xmlns=""><a href="s1842.html">1842-Basic Flow Under the PCT</a></li>
               <li xmlns=""><a href="s1843.html">1843-The International Search</a><ul>
                     <li><a href="s1843.html#d0e172347">1843.01-Prior Art for Chapter I Processing</a></li>
                     <li><a href="s1843.html#d0e172603">1843.02-Certain Subject Matter Need Not Be Searched</a></li>
                     <li><a href="s1843.html#d0e172803">1843.03-No Search Required if Claims Are Unclear</a></li>
                     <li><a href="s1843.html#d0e172835">1843.04-Procedure for Claims Not Required To Be Searched and for Claims That Are Unclear</a></li>
                     <li><a href="s1843.html#d0e172870">1843.05-Time Limit for Establishing the International Search Report and the Written Opinion of the International Searching Authority</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1844.html">1844-The International Search Report</a><ul>
                     <li><a href="s1844.html#d0e172999">1844.01-Preparing the International Search Report (Form PCT/ISA/210)</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1845.html">1845-Written Opinion of the International Searching Authority</a><ul>
                     <li><a href="s1845.html#d0e173906">1845.01-Preparing the Written Opinion of the International Searching Authority (Form PCT/ISA/237)</a></li>
                     <li><a href="s1845.html#d0e174931">1845.02-Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority,
                           or the Declaration (Form PCT/ISA/220)</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1846.html">1846-Sections of the Articles, Regulations, and Administrative Instructions Under the PCT Relevant to the International Searching
                     Authority</a></li>
               <li xmlns=""><a href="s1847.html">1847-[Reserved]</a></li>
               <li xmlns=""><a href="s1848.html">1848-Sequence Listings and Tables Related to Sequence Listings</a></li>
               <li xmlns=""><a href="s1849.html">1849-[Reserved]</a></li>
               <li xmlns=""><a href="s1850.html">1850-Unity of Invention Before the International Searching Authority</a></li>
               <li xmlns=""><a href="s1851.html">1851-Identification of Patent Documents</a></li>
               <li xmlns=""><a href="s1852.html">1852-Taking Into Account Results of Earlier Search(es)</a></li>
               <li xmlns=""><a href="s1853.html">1853-Amendment Under PCT Article 19</a></li>
               <li xmlns=""><a href="s1854-1856.html">1854-1856-[Reserved]</a></li>
               <li xmlns=""><a href="s1857.html">1857-International Publication</a><ul>
                     <li><a href="s1857.html#d0e182117">1857.01-Prior Art Effect of the International Publication</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1858.html">1858-[Reserved]</a></li>
               <li xmlns=""><a href="s1859.html">1859-Withdrawal of International Application, Designations, or Priority Claims</a></li>
               <li xmlns=""><a href="s1860.html">1860-International Preliminary Examination Procedure for Applications Having an International Filing Date On or After January 1,
                     2004</a><ul>
                     <li><a href="s1860.html#d0e182787">1860.01-International Preliminary Examination Procedure for Applications Having an International Filing Date Before January 1, 2004</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1861.html">1861-[Reserved]</a></li>
               <li xmlns=""><a href="s1862.html">1862-Agreement With the International Bureau To Serve as an International Preliminary Examining Authority</a></li>
               <li xmlns=""><a href="s1863.html">1863-[Reserved]</a></li>
               <li xmlns=""><a href="s1864.html">1864-The Demand and Preparation for Filing of Demand</a><ul>
                     <li><a href="s1864.html#d0e183157">1864.01-Amendments Filed Under PCT Article 34</a></li>
                     <li><a href="s1864.html#d0e183297">1864.02-Applicant’s Right To File a Demand</a></li>
                     <li><a href="s1864.html#d0e183417">1864.03-States Which May Be Elected</a></li>
                     <li><a href="s1864.html#d0e183461">1864.04-Agent’s Right To Act</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1865.html">1865-Filing of Demand</a><ul>
                     <li><a href="s1865.html#d0e183713">1865.01-The European Patent Office as an International Preliminary Examining Authority</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1866.html">1866-Filling in of Headings on Chapter II Forms</a></li>
               <li xmlns=""><a href="s1867.html">1867-Preliminary Examination Fees</a></li>
               <li xmlns=""><a href="s1868.html">1868-Correction of Defects in the Demand</a></li>
               <li xmlns=""><a href="s1869.html">1869-Notification to International Bureau of Demand</a></li>
               <li xmlns=""><a href="s1870.html">1870-Priority Document and Translation Thereof</a></li>
               <li xmlns=""><a href="s1871.html">1871-Processing Amendments Filed Under Article 19 and Article 34 Prior to or at the Start of International Preliminary Examination
                     in International Applications Having an International Filing Date On or After January 1, 2004</a><ul>
                     <li><a href="s1871.html#d0e184948">1871.01-Processing Amendments Filed Under Article 19 and Article 34 Prior to or at the Start of International Preliminary Examination
                           in International Applications Having an International Filing Date Before January 1, 2004</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1872.html">1872-Availability of the International Application File for International Preliminary Examination by the Examining Corps</a></li>
               <li xmlns=""><a href="s1873.html">1873-[Reserved]</a></li>
               <li xmlns=""><a href="s1874.html">1874-Determination if International Preliminary Examination Is Required and Possible</a></li>
               <li xmlns=""><a href="s1875.html">1875-Unity of Invention Before the International Preliminary Examining Authority</a><ul>
                     <li><a href="s1875.html#d0e185391">1875.01-Preparation of Invitation Concerning Unity</a></li>
                     <li><a href="s1875.html#d0e185503">1875.02-Reply to Invitation Concerning Lack of Unity of Invention</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1876.html">1876-Notation of Errors and Informalities by the Examiner</a><ul>
                     <li><a href="s1876.html#d0e185657">1876.01-Request for Rectification and Notification of Action Thereon</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1877.html">1877-Nucleotide and/or Amino Acid Sequence Listings During the International Preliminary Examination</a></li>
               <li xmlns=""><a href="s1878.html">1878-Preparation of the Written Opinion of the International Preliminary Examining Authority in International Applications Having
                     an International Filing Date On or After January 1, 2004</a><ul>
                     <li><a href="s1878.html#d0e186282">1878.01-Preparation of the Written Opinion in International Applications Having an International Filing Date Before January 1, 2004</a><ul style="list-style-type: none">
                           <li><a href="s1878.html#d0e187509">1878.01(a)-Prior Art for Purposes of the Written Opinion and the International Preliminary Examination Report</a><ul>
                                 <li><a href="s1878.html#d0e187677">1878.01(a)(1)-Novelty for Purposes of the Written Opinion and the International Preliminary Examination Report</a></li>
                                 <li><a href="s1878.html#d0e187723">1878.01(a)(2)-Inventive Step for Purposes of the Written Opinion and the International Preliminary Examination Report</a></li>
                                 <li><a href="s1878.html#d0e187807">1878.01(a)(3)-Industrial Applicability for Purposes of the Written Opinion and the International Preliminary Examination Report</a></li>
                              </ul>
                           </li>
                        </ul>
                     </li>
                     <li><a href="s1878.html#d0e187853">1878.02-Reply to the Written Opinion of the ISA or IPEA</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1879.html">1879-Preparation of the International Preliminary Examination Report</a><ul>
                     <li><a href="s1879.html#d0e188619">1879.01-Time Limit for Preparing Report in International Applications Having an International Filing Date On or After January 1, 2004</a><ul style="list-style-type: none">
                           <li><a href="s1879.html#d0e188804">1879.01(a)-Time Limit for Preparing Report in International Application Having an International Filing Date Before January 1, 2004</a></li>
                        </ul>
                     </li>
                     <li><a href="s1879.html#d0e188956">1879.02-Transmittal of the International Preliminary Examination Report</a></li>
                     <li><a href="s1879.html#d0e189042">1879.03-Translations</a></li>
                     <li><a href="s1879.html#d0e189228">1879.04-Confidential Nature of the Report</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1880.html">1880-Withdrawal of Demand or Election</a></li>
               <li xmlns=""><a href="s1881.html">1881-Receipt of Notice of Election and Preliminary Examination Report by the United States Patent and Trademark Office</a></li>
               <li xmlns=""><a href="s1882-1892.html">1882-1892-[Reserved]</a></li>
               <li xmlns=""><a href="s1893.html">1893-National Stage (U.S. National Application Filed Under 35 U.S.C. 371)</a><ul>
                     <li><a href="s1893.html#d0e189843">1893.01-Commencement and Entry</a><ul style="list-style-type: none">
                           <li><a href="s1893.html#d0e190008">1893.01(a)-Entry via the U.S. Designated or Elected Office</a><ul>
                                 <li><a href="s1893.html#d0e190240">1893.01(a)(1)-Submissions Required by 30 Months from the Priority Date</a></li>
                                 <li><a href="s1893.html#d0e190345">1893.01(a)(2)-Article 19 Amendment (Filed With the International Bureau)</a></li>
                                 <li><a href="s1893.html#d0e190402">1893.01(a)(3)-Article 34 Amendments (Filed with the International Preliminary Examining Authority)</a></li>
                              </ul>
                           </li>
                           <li><a href="s1893.html#d0e190492">1893.01(c)-Fees</a></li>
                           <li><a href="s1893.html#d0e190635">1893.01(d)-Translation</a></li>
                           <li><a href="s1893.html#d0e190737">1893.01(e)-Oath/Declaration</a></li>
                        </ul>
                     </li>
                     <li><a href="s1893.html#d0e191079">1893.02-Abandonment</a></li>
                     <li><a href="s1893.html#d0e191121">1893.03-Prosecution of U.S. National Stage Applications Before the Examiner</a><ul style="list-style-type: none">
                           <li><a href="s1893.html#d0e191193">1893.03(a)-How To Identify That an Application Is a U.S. National Stage Application</a></li>
                           <li><a href="s1893.html#d0e191308">1893.03(b)-The Filing Date of a U.S. National Stage Application</a></li>
                           <li><a href="s1893.html#d0e191506">1893.03(c)-The Priority Date, Priority Claim, and Priority Papers for a U.S. National Stage Application</a></li>
                           <li><a href="s1893.html#d0e191885">1893.03(d)-Unity of Invention</a></li>
                           <li><a href="s1893.html#d0e192440">1893.03(e)-Documents Received from the International Bureau and Placed in a U.S. National Stage Application File</a><ul>
                                 <li><a href="s1893.html#d0e192601">1893.03(e)(1)-Title of the Invention</a></li>
                              </ul>
                           </li>
                           <li><a href="s1893.html#d0e192624">1893.03(f)-Drawings and PCT Rule 11</a></li>
                           <li><a href="s1893.html#d0e192639">1893.03(g)-Information Disclosure Statement in a National Stage Application</a></li>
                        </ul>
                     </li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1894.html">1894-[Reserved]</a></li>
               <li xmlns=""><a href="s1895.html">1895-A Continuation , Divisional, or Continuation- in- Part Application of a PCT Application Designating the United States</a><ul>
                     <li><a href="s1895.html#d0e192774">1895.01-Handling of and Considerations in the Handling of Continuations, Divisions, and Continuations-In-Part of PCT Applications</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1896.html">1896-The Differences Between a National Application Filed Under 35 U.S.C. 111(a) and a National Stage Application Submitted Under
                     35 U.S.C. 371</a></li>
            </ul>  </div>
         </div>
      </div>  </div>
      

  <div style="text-align:right"> Last Modified: 

     

    03/27/2014 10:10:33 

  </div>

</div>

</div>




<!-- End of footer2.html -->


   </body>
</html>